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Abstract
Adhesion-based cell capture on surfaces in microfluidic devices forms the basis of numerous
biomedical diagnostics and in vitro assays. Solid surface microfluidic platforms have been widely
explored for biomedical diagnostics since samples can be precisely and reproducibly manipulated
under well-defined physicochemical conditions. However, at these small length scales, the fluid
dynamics are dominated by the high surface-to-volume ratio and interfacial phenomena limiting
device performance at high flow rates. In contrast, cell homing to porous vasculature is highly
effective in vivo during inflammation; stem cell trafficking and cancer metastasis. In this work, we
demonstrate that fluid-permeable surface functionalized with cell-specific antibodies can promote
efficient and selective cell capture in vitro. This architecture might be advantageous due to enhanced
transport due to fluid field modification leading to diverted streamlines towards the surface.
Moreover, specific cell-surface interactions can be promoted due to reduced shear, allowing gentle
cell rolling and arrest. Together, these synergistic effects enable highly effective target cell capture at
flow rates over an order of magnitude larger than existing devices with solid surfaces. Additionally,
in this study, we overcome a major limitation relevant to porous surfaces due to formation of
stagnant layers of cells from non-target background population. These stagnant layers are detrimental
to device performance as they act to reduce interaction of the cells with the reactive surface thereby
reducing capture efficiency. We theoretically and experimentally understand the mechanisms for
formation of the stagnant bioparticle layer in microfluidic devices and define a parameter space for
optimal operation of the device over long periods of time. Key insights from these studies,
collectively allow us to design a spatially modified microfluidic devices that allow us to isolate
cancer lines as low as 5 cells/mL spiked into buffy coat.
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Chapter 1
Introduction
The efficient isolation of specific cells in lab-on-a-chip platforms is important for many
applications in clinical diagnostics and biomedical research. These cells can be classified as
prevalent cells (~10,000's cells in a mL of blood) or rare cells (~ as low as 1 cell in a mL of
blood). Separating cells based on recognition of characteristic molecules, or more commonly
known as, immuno-chromatography based separation, represents a highly specific way of
isolating otherwise homogenous population of cells. In the past decade, a large number of
microfluidic devices have been designed for isolating specific cells based on
immuno-chromatography. However, these devices use solid surfaces for immobilization of
moieties complimentary to the receptors on cells of interest. Use of solid surfaces poses certain
critical challenges in capturing specific cells at high flow rates: The first limitation in this regime
arises because the transport of analytes to the solid surface is slow compared to the speed of
transport through the microfluidic device. This is particularly problematic at high flow rates due
to rapid advection of analytes through the device (analogous to high Peclet number), as well as
poor mixing of viscous flows (low Reynolds number). The second limitation subsequently arises
because of insufficient time required for reaction of analytes with the surface. This is particularly
problematic for cells moving rapidly across the surface, since they require the formation of
multiple adhesive bonds between the characteristic molecules on the cell surface and the
complimentary antibodies on the solid surface, to be fully arrested.
In this thesis, we study the effect of fluid permeable nano-porous membrane surface integrated in
microfluidic devices on specific cell capture at high flow rates. We show that these fluid
permeable surfaces allow for flow field modification, and allow bulk and surface cooperative
mechanisms to efficiently isolate specific cells. Additionally, in this thesis we study the effect of
background non-specific cells which lead to formation of stagnant 'cake' cell layers. These cake
layers are reminiscent of many chemical engineering processes such as concentration of slurries
in food and beverage industry, pretreatment of water and microbial separation in the
biotechnology industry, and once formed significantly reduce capture efficiency of specific
17
target cells. We model the transient and steady state conditions of stagnant cell layer formation
and extend our findings to improve device design and alleviate the above mentioned problems.
Further, simple device design and commercially available porous surfaces, allow scaling up of
the device, which allow us to reach the goal of high throughput cell capture in microfluidic
devices.
1.1 Motivation
The identification, selection and separation of a subpopulation of target cells from a larger
heterogeneous population is essential for blood-based point-of-care diagnostics, personalized
therapies and cell biology [9-11]. These cells of interest may be rare and present in
extraordinarily low numbers relative to the general population, necessitating the processing of
large sample volumes in order to accumulate a useful number. For instance, 1 mL of whole blood
contains billions of red blood cells, millions of white blood cells, thousands of hematopoietic
stem cells, hundreds of endothelial progenitor cells and dozens of circulating tumor cells (Fig. 1-
1) [12, 13]. Thus, even a perfectly efficient separation scheme requires at least 10 mL of whole
blood to capture a usable sample of the rarest cell types, which must be rapidly processed to limit
degradation and provide timely information to patients.
10000 ne' Pt-o"s Prevalent
----- i$*NL cells
10 00L
01
0001 Rare cells
0001 001 01 1 10 30
miL Whole Blood for 100 Target Cels
Prevalent cells 0 Rare cells
Fig. 1-1 Blood composition and frequency of rare cells for disease diagnosis
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A number of approaches have been demonstrated to separate subpopulations of cells through
their differential physical and biochemical phenotypes, which serve as "handles" for direct
manipulation. For example, physical fields can partition a complex mixture of cells based on
size, shape, deformability, density, electrical, magnetic or optical properties [10, 14]. These
approaches are advantageous since they can be label-free and relatively high-throughput, but are
often confounded by the considerable variability found even within a specific cell type. Instead,
greater specificity can be achieved using molecular recognition of unique cell surface markers.
Cells in solution can be labeled and subsequently sorted using fluorescent molecules [15] or
magnetic beads [16]. Alternatively, cells can be captured on solid surfaces functionalized with
ligands complementary to a specific cell surface receptor [17, 18]. This approach has been
previously utilized to isolate neutrophils [19, 20], monocytes [20], lymphocytes [20-22],
fibroblasts [23], endothelial progenitor cells [24], hematopoietic stem cells [25], mesenchymal
stem cells [26] and circulating tumor cells [27-32]. In these schemes, specific cell adhesion
depends on the interactions between the cell and surface, requiring the operating conditions to be
carefully controlled.
Microfluidic platforms have been widely explored for biomedical diagnostics since samples can
be precisely and reproducibly manipulated under well-defined physicochemical conditions. At
these small length scales, the fluid dynamics are dominated by the high surface-to-volume ratio
and interfacial phenomena [33, 34]. Although these effects have been cleverly exploited for
various applications, they severely hinder throughput for analyte capture on solid surfaces [35,
36].
The first limitation in this regime arises because the transport of analytes to the surface may be
too slow compared to the speed of transport through the microfluidic device. This is particularly
problematic at high flow rates due to rapid advection of analytes through the device (analogous
to high Peclet number), as well as poor mixing of viscous flows (low Reynolds number). These
issues can be partially overcome by increasing the effective surface area [27, 30, 31], as well as
using "herringbone" chaotic micromixers to disrupt fluidic streamlines through the microfluidic
device [28, 29, 37].
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The second limitation subsequently arises if the reaction of analytes with the surface does not
have sufficient time to occur. This is particularly problematic for cells moving rapidly across the
surface, since they require the formation of multiple adhesive bonds to be fully arrested [38].
Indeed, any bonds that do form between cellular receptors and surface-immobilized ligands are
more likely to dissociate at high shear rates [39]. On the other hand, a certain threshold shear rate
is necessary for adhesion-based capture to occur selectively [17], since weaker non-specific
molecular bonds are pulled apart more easily. This mechanism has been used to select for certain
subpopulations with differential expression levels using a precisely controlled shear rate [21, 22].
Another danger is that cell sedimentation may dominate at low flow rates, which would further
decrease selectivity. Overall, the effectiveness of adhesion-based capture is limited at high flow
rates both by transport of cells to the surface as well as the subsequent reaction of cells with the
surface.
Here, we show that microfluidic devices incorporating porous, fluid-permeable surfaces
functionalized with cell-specific antibodies can be used to capture a rare subpopulation of target
cells with excellent efficiency, selectivity and throughput. The effectiveness of this platform
arises both from enhanced mass transport to the porous surface, as well as enhanced cell-surface
interactions that promote dynamic rolling adhesion with high specificity. These cooperative
mechanisms enable optimum performance at extremely fast flow rates. These flow rates are over
an order of magnitude faster than what can be achieved with conventional devices.
1.2 Thesis Structure
This thesis introduces the incorporation and use of antibody functionalized porous surfaces for
specific cell capture at high flow rates and their advantage over the solid counterparts. Chapter 2
highlights some of the major advancements on the macro- and micro- scale lab on chip cell
separation systems. We highlight some of the most prevalent methods of cell separation with a
specific focus on immuno-chromatography based methods. Additionally in this chapter, we
introduce the reader to the current use of porous surfaces in biology and cell separation. An
understanding of the limitations of these current platforms elucidates the motivation for this
thesis.
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In chapter 3, we describe the fabrication methodology for incorporating commercially available
nano-porous surfaces into the micro-fluidic devices. Methods to sandwich porous surfaces in
microfluidic devices have previously been described. However, in order to allow large flow rates
in these channels, we optimize one of these methods to insure device integrity during the course
of these experiments. Additionally, in chapter 3 we investigate different known functionalization
strategies for different porous surface materials and optimize the pore sizes needed to achieve
enhanced mass transport and surface interactions of cells with the surface without physical
trapping of cells within the pores. Additionally, we introduce and describe different modes of
device operation that are a characteristic of every experiment. Lastly, we develop a lumped
resistance model for the two-layered porous surface device which describes the use of high
external resistances in reliably performing the experiments and measurement of the device
function through fluid flux measurements. This model is the mainstay of replicating capture
efficiency results, even in the presence of porous surface variations in commercially available
membranes.
In Chapter 4, the effectiveness of the two channel micro-fluidic platform with sandwiched
porous surface platform to capture specific cells is studied. An analytical model for cell
transport to the porous surface using Faxen's Law is developed allowing insight into the linear
relationship between permeation flux through the porous surface and the total percentage of cells
that get convected to the porous surface. Once on the surface, we understand the motion of
unencumbered cells on the porous surface and derive an analytical expression that highlights the
reduced velocity of cells on porous surface and compare it to Goldman's equation for particle
rolling close to a solid wall. Additionally, we present a state diagram generated from
experimental conditions that elaborates the rolling velocity of cells on porous surfaces as a
function of shear stress and permeation flux. The state space model explains the equivalency
relationship that exists between shear and permeation flux for different channel dimensions
thereby providing a general rule of thumb for designing devices, depending on the desired
application. We utilize these results to demonstrate the effectiveness of porous surface in
capturing various cell lines and demonstrate that the flow rates under which capture takes place
is over an order of magnitude faster than what can be achieved with conventional devices.
Capture of different cancer cell lines with varying levels of surface antigens demonstrates the
versatility of the device in capturing cells with low and high expressing Ep-CAM receptors.
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Lastly, we compare the theoretical and the experimental rate of capture of in our device using the
Bell model.
Chapter 5 studies the effect of permeation flux on target cell capture efficiency in the presence of
significantly larger number of non-specific background cells. Using prior work from Romero and
Davis, a steady state and transient model for formation of stagnant 'cake' cell layer on the
surface is studied which allows optimization of controllable operational parameters such as fluid
shear stress, permeation flux and cell feed concentration for and avoiding the detrimental effects
of stagnant layer formation on rare specific cell capture. In this chapter, careful study of the
phenomenon allowed us to understand the inevitable dependence of the cake layer formation on
the porous surface on cell feed fraction and permeation flux. In our study, we find two
mechanisms responsible for formation of the stagnant layer. Firstly, the critical distance from the
entrance beyond which the shear rate is not strong enough to sweep non-specifically captured
particles tangentially. Secondly, we investigate and alleviate the reduction in translational shear
forces due to wall effects. Temporal data on stagnant layer formation indicates that even under
optimal critical distance conditions, microfluidic channel "edge effects" reduce shear at the
edges and promote white blood cell layer formation. By engineering nano-pore distributions
through a channel width we control these "wall effects" and shift the tangential shear to
permeation flux ratio back into the optimal regime. We extend the same principal into a multi-
channel indented microfluidic device where we demonstrate capture efficiency of ~70% for rare
cancer cell numbers (-5 cells /mL) by processing -48 mL of sample in 1 hr.
Chapter 6 summarizes the main findings of the previous chapters and provides suggestions for
future directions. In this chapter we discuss the exciting possibilities that have opened up as a
result of the insights developed through the theoretical and experimental analysis of results in
this thesis. Firstly, the use of the system developed during this thesis in conjunction with the
developed theory towards a multiplexed cell arrest device can allow for understanding of
interactions between the cell antigens and the complimentary antibodies. These studies can shed
light on important properties of cells, the complimentary antibodies and the interactions between
them that lead to "arrest" or "no arrest" modes. Secondly, the same device can be used for
building an in-vitro model for cell trafficking usually encountered in bio-mimetic settings during
cancer cell chemotaxis and leukocyte homing and finally, the rigorous understanding of the
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fluidic forces in this thesis can enable us to engineer a "perfect" porous surface using silicon
nitride substrate which can enable isolation of rare cells from clinical samples in an extremely
well controlled manner thereby providing opportunity for clinical application.
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Chapter 2
Background and Prior Work
Identification, detection and separation of cells from complex mixtures such as blood and sputum
have become the mainstay for diagnosis and prognosis of many diseases [21, 40-43]. Low
numbers of these cells in some cases such as, circulating tumor cells in cancer, antigen specific T
cells in tuberculosis and fetal cells in prenatal diagnosis necessitate the use of large volumes of
these samples in order to accumulate a useful number for diagnosis. In this chapter we will focus
on macro and micro scale technologies that leverage different physical as well as bio-chemical
properties of cells for identification and isolation. Section 2.1 will discuss some of the traditional
macro- techniques used in clinical, research and industrial settings for large volume sample
processing and discuss their advantages and disadvantages. In section 2.2, we explore
microfluidic technologies that leverage the use of forces unique and effective on micron scales
for cell separation. In section 2.3 we introduce separation of specific cells on the principles of
immunochromatography and discuss different variants of this technique (FACS, MACS) on
macro scale. Section 2.4 explores the use of microfluidic devices for specific cell capture in
microfluidic devices. Section 2.5 discusses the historical account of porous surfaces in
microfluidic and their use in immonochromatography based capture. Finally, section 2.6 we
discuss limitations in currently microfluidic particle separation technologies and how our work
with nano-porous surfaces in microfluidics has the potential to overcome some of these
challenges.
2.1 Macroscale separation based on physical properties
Importance of bioparticle separation has led to development of several techniques on a
clinical (Centrifugation), industrial (Filtration) and research (Electrophoresis) level in the
past century. In this section we will discuss some of the most prevalent and commonly used
techniques that leverage physical properties of bioparticles for separation. Traditional
macroscale technologies techniques primarily make use of physical properties such as size,
shape and density and mobility induced by electric field forces. These techniques are
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usually used as pre-concentration techniques upstream of the more specific techniques.
Even though these pre-concentration techniques are able to process large volumes of
samples in a short time (aka high throughput), they suffer from severe lack of sensitivity
and specificity in samples that have low target cell numbers, rendering them unsuitable for
use. A few examples of the most common techniques are elucidated in this section.
Centrifugation: Often used as the first step in preparation of biological samples, centrifugation
has established its position in the clinical and research settings as one of the most instrumental
tools for separation of bioparticles on the basis of size and density. Sophisticated ultracentrifuge
machines today can generate centrifugal forces on the order of lx10 6g, thereby expediting
sample processing and increasing resolution of bioparticle detection on the basis of size and
relative density difference of the bioparticle and the media (Fig. 2-la). The method of
centrifugation accelerates the process of sedimentation of various cellular components in the
sample and allows concentration of bioparticles with similar size and density in "bands"(Fig. 2-
1 b). Improvements over this initial principal have been achieved by using density enhancing
media such as (1) Ficoll (a polysaccharide media used for separation blood into its cellular
components) and (2) Percoll (a coilloidal silica media used for separating cells, viruses and
organelles), and sugar media such as sucrose.
(a) (b)
Plasma
White Blood Cells
Red Blood Cells
Fig. 2-1 (a) Modem day ultracentrifuge (b) Bands of different components of blood after
ultracentrifugation
Size Based Filtration: Size based filtration using porous surfaces is one of the most commonly
used methods to separate mixture of bioparticle populations based on size and shape differential
and when the biomolecular properties of the cells are not well known. Flowing a sample through
the device bearing the porous surface, bioparticles larger than the pore size are unable to pass
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through the surface and get retained on the surface, whereas the smaller sized bioparticles pass
through with ease (Fig.2-2a). Due to operational ease and its scalability, size based filtration has
been utilized in large scale industrial applications such as separation of bacteria and viruses from
water in water [1] and colloidal particles in coal slurries [44], and clinical applications such as
toxins from blood in hemodialysis [2]. One major disadvantage of this configuration of filtration
is the rapid deterioration of the device performance due to blocking of pores as a consequence of
particle retention [I]. We will discuss the mechanisms behind fouling and blockage of these
pores in Chapter 4 and discuss ways to assuage it.
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Fig. 2-2: (a) Comparison of removal characteristics of different pressure driven membrane
processes [1] (b) Large scale industrial modules containing porous surfaces for removal of
bacteria from water [1] (c) Modem day hemo-dialysis machine for removal of toxins from blood
using 15 nm porous surface [2]
2.2 Microscale bioparticle separation techniques based on physical
characteristics
Use of microfabrication techniques in designing devices over the past few decades has opened up
possibilities to exploit optical, dielectrophoretic, acoustic and fluidic forces, , which become
relevant and powerful on the length scales of the bioparticle. These forces allow accurate
manipulation of the local bioparticle environment down to the single particle level. Although
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selective, weak nature of some of these manipulative forces limits throughput of sample
processing.
Optical manipulation: Optical forces provide a precise, non-contact and contamination free
method to identify and select cells from a mixture. The most common technique utilized using
this principle is optical tweezers where a focused laser confines dielectric particles in a 3
dimensional environment and imparts attractive or repulsive forces based on the mismatch of the
refractive indices [45, 46]. Manipulation of bioparticles from a few angstroms to ten's of microns
is possible using this technique.
Dielectrophoretic manipulation (DEP): Dielectrophoretic manipulation of cells is
analogous to optical forces. The dielectrophoretic manipulation force depends on the clausius-
mossotti factor, which takes into account the dielectric constants of the bioparticle and the
surrounding media in a non-uniform magnetic field that imparts attractive or repulsive forces.
The phenomenon was first described in the 1950s by Henry Pohl and since has been utilized by
many groups to sort cells. Use of microfabrication techniques allow fabrication of electrodes of
various materials that generate well controlled non-uniform electric fields. One such example is
the use in a microcytometer where an array of electrodes use dielectrophorretic forces to hold the
cells in place as the surrounding media flows by and the optical system luminiscently
interrogates the held particle for identification [47]. These forces have also been used to pattern
and concentrate bioparticles ranging a few microns upto ten's of microns [3, 48, 49].
(a) (b)
Microchannel (top)
v v v. v. v V
Fig. 2-3: (a) Schematic of the interdigitated electrodes and DEP forces with respect the sample
flow (b) fractionation of tumor cells and other blood components on the DEP chip [3]
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Acoustic manipulation: Acoustic sorting provides yet another method for bioparticle sorting,
concentration and patterning by application of externally controllable field [50-52]. In this
method, ultrasonic standing waves produce stationary pressure gradients at well defined intervals
(nodes) which in liquid medium imparts radial forces to position cells at specific intervals i.e. at
the nodes. Concerns over cell due to the radial force and rise in temperature have been raised.
However, a recent study by Johanson shows that the amount of force on the bioparticles is ~ 0.5
nN, which is similar to the forces applied using optical and dielectrophoretic forces [53].
Additionally, acoustic forces provide a higher continuous throughput over the optical and
dielectrophoretic external fields.
(a) (b)
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Fig. 2-4: (a) Schematic illustrating the principle of acoustic separation by standing surface
acoustic waves (SSAW) generated using interdigital transducers (IDT). The varying acoustic
forces repositions the larger cells closer to the channel center and smaller cells farther from the
center (b) Cells of varying sizes align at distinct positions across the microchannel cross-section
based on the acoustic primary radiation force experienced.
Fluid force manipulation: One of the biggest advantages of miniaturization of the existing
macro scale cell sorting principles is in manipulation of fluid forces. Laminar flows simplify the
Navier-Stokes equations and therefore allow understanding and control of bioparticles in
microfluidic channels through clever design.
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Fig. 2-5: (a) Top schematic shows asymmetric obstacles separating out particles of different
size. The bottom figure shows separation of 0.4 pm and 1 pm beads and the respective
trajectories. (b) Top schematic shows the focusing of particle in an annulus. The middle figure
illustrated the different forces that determine the eullibrium position of focusing and the bottom
figure shows focusing of fluorescent fluid in the microfluidic channels.
Deterministic hydrodynamics make use of low Reynolds number laminar flows (Re<<1) in
microfluidic devices. The approach makes use of the asymmetric bifurcations which act as
obstructions to the particle in the flow direction (Fig. 2-5a). Based on the size and deformability,
separation of RBC's, WBC's, bacteria and solid latex particles have been achieved [54, 55].
In contrast to the low Reynolds number regime used for deterministic lateral displacement where
viscous forces dominate over inertial forces, for large Reynolds number ( Re > 1), the vice
versa is true. These conditions can be achieved at high flow rates, which enable high throughput
processing of samples. These inertial forces tend to push or 'focus' the particles in the channel to
equilibrium positions which are determined by Reynolds number, ratio of the particle diameter to
channel dimensions and the shape of the particles (fig. 2-5b). Several groups have studied this
phenomenon and reported the optimal regimes under which this focusing is high quality [56-58].
Applications of inertial focusing have been used in making micro-scale flow cytometers [59].
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2. 3 Separation of bioparticles based on specific biomolecular
recognition
Separation using specific biomolecular recognition ("affinity chromatography") exploits use of
unique markers on surfaces of cells of interest. In contrast to the purely physical methods of
separation, this technique is highly specific and allows differentiation between cells that are
otherwise similar in shape, size and density. Selected complimentary molecules identify the
surface markers on target cells by forming biochemical bonds. Various methods have been
devised in order to leverage this technique identifying and sorting target cells in solution (FACS
and MACS) or on a fixed substrate. Some of the most famous ones are discussed in this section.
Flow activated cell sorting: Fluorescence activated cell sorting (FACS) is widely used in
laboratory and clinics. Due to its high sensitivity and mature technology, FACS has become the
technique of choice to use commercially [60]. The target cells are focused using sheath flow
around the sample injection port to file the cells in the sample within a confined region. The cells
are identified via the fluorescent markers tagged onto the complimentary molecules that bind to
the surface markers or cytosolic proteins (Fig. 2-6a). The detector in the FACS detects the
presence or absence of the fluorescent signal from each cell and records it [4]. Whereas there are
several advantages to FACS some of the limitations include clogging, contamination, cell
viability and the expensive nature of the instrument. In order to alleviate some of the above
mentioned disadvantages, various groups have developed a microfluidic versions of flow
cytometers. One typical format of a p-flow cytometer is the T-junction design where, similar to
the original FACS, sample is injected through one port and the sheath flow provides a narrow
band of ordered cells which can be interrogated one at a time by the detected. Another variation
is generation of droplets that encapsulate cells in order to preserve cells from excessive shear and
maintain viability (Fig. 2-6b). Besides, portability, cheap cost and ability to parallelize these
devices to increase throughput, microfluidics reduces the drag experienced by the cells due to
droplet switching compared to flow switching in its macro counterpart [61].
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Fig. 2-6 (a) FACS schematic illustrating the principle of FACS (b) Variation of the original
FACS principal where droplets are generated encapsulating cells are generated to preserve cells
from excessive shear at high flow rates [4].
Magnetically activated cell sorting: A variant to FACS is Magnetically Activated Cell Sorting
(MACS), where magnetic beads instead of fluorescence, bear the recognition molecule that label
the target cells [62]. Once labeled with magnetic beads, the target cells are picked out from the
general population by using a magnetic field gradient. One of the advantages of MACS lies in
the flexibility of its application in either batch or continuous processing modes on large scales.
Batch processing involves placement of magnets next to a column containing ferromagnetic
material where alternating presence and absence of magnetic fields collects the cells [63]. In
continuous processing, a quadrapole magnet is placed next to liquid columns and cell solution
flows through the column. Cells attached to magnetic beads get deflected, whereas the others
flow straight through [64]. Similar devices are also implemented in microfluidic formats. These
microfluidic MACS devices can be broadly classified into two categories: active and passive
traps. In active traps, electrical power is used to generate the desired magnetic field
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characteristics through on-chip electromagnets (Fig. 2-7a). In contrast, a passive trap uses a
permanent magnet, with on chip iron or nickel elements acting as field gradient concentrators
(Fig. 2-7b) [65, 66]. Advantages to MACS include the possibility of collecting large number of
target cells at the same time and low cost. However, some of the drawbacks include time
consuming and sensitive process of labeling the cells with magnetic beads, low sensitivity and
removal of unbound beads [16].
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Fig. 2-7 (a) Active method of magnetically activated cell separation using on chip fabricated
coils [5] (b) Schematic of passive MACS using an external magnetic to deflect magnetically
attached cells [6].
2.4 Immunochromatography separation using microfluidic devices
Use of specific cells through biomolecular recognition has recently become popular due to the
recent developments in the field of microtechnology, which have opened up avenues for studying
chemical and biological samples in microfluidic devices, and have started playing important
roles in tissue engineering, neurobiology, cell biology and cell sorting. Sensitivity of
immunochromatography is increased by the use of microfluidic devices, where
microenvironments can be controlled precisely in order to facilitate the biochemical reactions
between the complimentary molecules. In contrast to capturing target particles in solution like in
FACS/MACS, specific cell capture can be achieved by immobilizing complimentary molecules
on the solid surfaces of the microfluidic devices. By controlling the fluidic forces in the
microfluidic laminar regime, several groups have used clever design to isolate target cells from
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the general population. This methodology has several advantages over the FACS or MACS
method of separation using immunochromatography. Firstly, capturing cells on microfluidic
solid surfaces does not require pre-mixing of the samples with labels such as magnetic beads and
fluorophores. Secondly, Capturing cells on solid surfaces allows for simple addition of
subsequent steps for cell lysis, detection and amplification. Thirdly, expensive and bulky
components such as lasers and permanent magnets are not required. Lastly, being able to control
the fluid dynamics in microfluidic device allows greater reliability in results.
Within a microfluidic device several factors such as shear stress, surface topography and
concentration, specificity and concentration of immobilized adhesive molecules as well as the
target cell type affect cell adhesion in microfluidic devices. Various groups have optimized
functionalization with the adhesive molecules in order to maximize cell capture [67-70]. For all
these affinity based microfluidic devices, the sample is processed in two steps. The first step,
"capture step", aims at capturing the specific cells, whereas the second step, "washing step",
removes the non-specifically bound cells on the surface using a washing buffer solution.
Likewise, models describing flow characteristics of the fluid on cell capture for various device
designs have been studied. For example Cheng and colleagues developed a straight rectangular
channel device with immobilized anti-CD4 immobilized on the surfaces using silence chemistry.
The study demonstrated the capability of the device to separate CD4+ T cells. Optimization of
the shear stress under which only CD4+ T cells would stick but not the CD4+ monocytes was
characterized in this study (Fig. 2-8a) [71]. However, this device geometry suffers from mass
transport problems at high flow rate, which reduce the ability of the target cells to contact the
reactive surface. This is a big hurdle in cases where the number of cells in the sample is rare
(<100 cells/mL) (Section 2.4). By making parallel channels this problem can be partially
alleviated, however it comes at the cost of increasing real estate and hence larger area over which
rare cells need to be detected (Fig. 2-8b). In order to increase the encounter between the target
cells and hence the sensitivity of the device, pillars (Fig. 2-8c) [40] and "herringbone"[72] (Fig.
2-8d) like structures functionalized with specific antibodies are built on the microfluidic surface.
These devices modify the parallel streamlines in the straight channel and allow greater
interaction of cells with the antibody covered surface. These devices demonstrate ability to
capture small numbers of circulating tumor cells from whole blood. However, like the flat
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channel devices these devices also suffer from capture of specific cells at low flow rates. In order
to alleviate the low flow rates in these devices (< 0.3 mL/hr) parallel channels are fabricated. As
microfluidics provide a predictable fluidics environment, Adams. et. al. desgined curvy channels
of small dimensions (30 pm x 45 pm) using deen flows to enhance specific cell capture
(Fig. 2-8e) [35] and Yang et. al. designed a combinatorial chip consiting of pillar and herring
bone pieces that allow for modified streamlines towards the surfaces even in the laminar flow
regime (Fig. 2-8f) [37]. For all of the above mentioned microfluidic devices, the sample is
processed in two steps. The first step involves optimizing for the ideal fluid conditions to capture
specific cells. The second step, consists of using a washing buffer to "wash away" all the loosely
bound cells on the surface to increase purity of capture.
(a) (b)
(c) (d)
(e) (f)
Fig. 2-8 (a) Schematic of a single straight rectangular microfuidic channel and fluid streamlines.
(b) Multiple straight rectangular channels with blood in order to improve throughput (c) SEM of
a cancer cell immobilized on an EpCAM coated micro-Silicon pillar (d) Schematic of "herring
bone" indentations modifying fluid and particles streamlines to increase interaction with the
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antibody coated surface (e) Narrow curved channels fabricated using fluidic forces to capture
cells (f) Hi aspect ratio CNT forests ("tiny" pillars) developed in conjunction with the herring
bone top to enhance specific cell capture.
2.5 Historical use of Porous Surfaces in Microfluidic Devices
Conventionally, solid materials such as glass, silicon, gold and polymers have been used in
microfluidic devices. However, recent developments in rigid substrates such as carbon nanotubes
as well as innovations in highly controlled porous membranes and monoliths have inspired
construction of devices integrating porous surfaces. Incorporation of porous elements have found
applications in cell culture, basic chemotaxis studies, microdialysis, tissue engineering and
filtration [73]. In this section, we describe a broad class of porous used for cell separation.
Carbon Nanotubes: Carbon Nanotubes (CNT's) have been used in a wide range of biomedical
applications because of their unique electrical, thermal and surface properties and
biocompatibility with biological samples. Application in most of these areas make use of
covalent [74] and non-covalent [75, 76] methods of functionalizing biomolecules to the CNT
surface. For example, Chen et. al. modify fluid fields by patterned antibody functionalized CNT
forests permeable to fluid, to increase "interception efficiency" and specific cell capture
efficiency of various size bioparticles by 6 fold [7]. CNT forests provide an unprecedented
increase in surface area while maintaining a high porosity (~99%) because of stable structure
formations, even at high aspect ratio (Fig. 2-9 a,b,c). Additionally, CNT fibers exhibit unique
semi-conductive properties and allow label free detection of charged biomolecules by acting as
field effect transistors and creating gating effects [77, 78]. CNT's have also been explored as
drug delivery vehicles. They possess the unique property of getting internalized by mammalian
cells and have therefore been used for chemical and thermal destruction of cancerous cells [79,
80]. Despite its functional uses, CNT integration into microfluidic devices for specific bioparticle
separation at high flow rates remains cumbersome and unreliable due to their brittle nature,
involved growth and fabrication, and limited scalability.
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Fig. 2-9 Scanning electron micrographs (SEMs) of patterned VACNT elements (a) A 200pm
diameter single post (b) An array of 20pm diameter posts (c) Nanostructure of a VACNT forest
[7]
Monoliths: Porous monoliths have been traditionally fabricated inside microfluidic devices by
injecting polymer solutions, which are then polymerized using free radicals and UV initiation.
Monoliths with different porosities (30% - 70%) can be synthesized by varying the
concentrations of organic solvents, monomers and free radical initiators [81]. Applications of
porous monoliths, include size based filtration, efficient mixing, and antibody-based specific
bioparticle capture, and are similar to the macro scale chromatography columns using solid
supports (Fig. 2-10). Even though monoliths provide an easy method for forming random porous
structures inside microfluidic devices, diversity in porosity and flow dynamics lead to
considerable variability in specific cell capture from device to the other.
Fig. 2-10 Scanning electron micrograph of a porous monolith formed inside a microfluidic
channel using UV initiation.
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Porous membranes: Membranes are the most widely used porous surface in microfluidic
devices due to ease of integration, scalability, low cost and a large range of selection of
commercial "off the shelf' application specific surface chemistries. Briefly, two kinds of porous
membranes are commercially available. Track etched membranes are formed when high energy
ionic particles are bombarded through polymers like polycarbonate, Teflon etc and create
through holes in the substrate (Fig. 2-1la).The second type of membranes are the mesh
membranes with interwoven fibers. These membranes allow fluid to pass through normally as
well as tangentially and are usually thicker than the track etched membranes (Fig. 2-11 b). These
porous surfaces allow passage of fluid normal to the surface through these holes. Successful
incorporation of membranes in microfluidic devices requires leakage free integration. While
most microfluidic devices use "glue, alignment and clamp" method [82], photochemical methods
have also been developed to achieve constructs that can withstand pressures greater than 200 kPa
without leaking or bursting [83]. De Jong et. al. provide a comprehensive review of how to select
a membrane focusing on the material, structural type and integration techniques [73]. These
integration techniques have opened possibilities for pre-concentration, purification,
microdialysis, chemotaxis and vascularization studies over a long period of time using
microfluidics [73]. Even with the advent of other exciting applications mentioned in previous
sections, size based filtration of bioparticles remains the most common use of porous membranes
in microfluidics. For example, Kim et al. [84] integrate different functions on a microfluidic
device by removing of cells from blood, separating of HDL, and signal generation on a enzyme
embedded membrane by using multiple membranes. However, like other size based separation
methods described in section 2.5, the filtration achieved with porous membranes does not give
specific particle selection.
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bFig. 2-11 (a) Scanning electron microscopy of a track etched polycarbonate membrane (b) SEM
of a cellulose mesh type porous surface
2.6 Some Limitations of current microfluidic devices in cell sorting
Over the past decade, the field of microfluidics has revolutionized cell sorting. As discussed in
sections 2.2, 2.4 and 2.5, microfluidics has provided scientists with the ability to cleverly control
flow characteristics, use low sample volumes and automate assays. However, depending on the
cells of interest, the number of rare target cells available for capture varies greatly in a milliliter
of blood. For example 1 mL of blood on an average contains 10,000 dendritic cells, but only has
~ 20 circulating tumor cells and less than 5 fetal cells (Fig. 2-13). This necessitates large volume
of sample to be processed in order to accumulate a useful number of cells, which requires high
sample flow rates in the device. Sample processing at high flow rates poses three critical
challenges: (1) Decreased transport of cells to the reactive surface (2) High shear stress and
decreased interaction time of cells with the reactive surface (3) Formation of stagnant layers of
non-specific cells on porous surface precluding optimal performance.
Mass Transport Limitation: The first limitation at flow rates arises because the transport of
analytes to the surface may be too slow compared to the speed of transport through the
microfluidic device. This is particularly problematic at high flow rates due to rapid advection of
analytes through the device (analogous to high Peclet number), as well as poor mixing of viscous
flows (low Reynolds number). These issues can be partially overcome by increasing the effective
surface area [27, 30, 31], as well as using "herringbone" chaotic micromixers to disrupt fluidic
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streamlines through the microfluidic device [28, 29, 37]. In this thesis, we describe the use of
porous surface to enhance mass transport towards the antibody functionalized reactive surface.
Receptor-Antibody Reaction Limitation: The second limitation subsequently arises if the reaction
of analytes with the surface does have sufficient time to occur. This is particularly problematic
for cells moving rapidly across the surface, since they require the formation of multiple adhesive
bonds to be fully arrested [38]. Indeed, any bonds that do form between cellular receptors and
surface-immobilized ligands are more likely to dissociate at high shear rates [39]. On the other
hand, a certain threshold shear rate is necessary for adhesion-based capture to occur selectively
[17], since weaker non-specific molecular bonds are pulled apart more easily. This mechanism
has been used to select for certain subpopulations with differential expression levels using a
precisely controlled shear rate [21, 22]. Another danger is that cell sedimentation may dominate
at low flow rates, which would further decrease selectivity. Overall, the effectiveness of
adhesion-based capture is limited at high flow rates both by transport of cells to the surface as
well as the subsequent reaction of cells with the surface. In Chapter 4 we define an optimal
regime where enhanced mass transport to the surface and adhesion-based capture of selective
cells co-exist.
Stagnant Layer Formation on Porous Surfaces: When operating at high flow rates without being
transport limited on porous surfaces, a different complication arises - excess build-up and fouling
of cells, known as concentration polarization and "caking" [85]. This is a well known issue
encountered during separation processes that completely remove all solid particles, such as those
based on cross-flow filtration [86]. Indeed, a number of hydrodynamic mechanisms have been
explored to suppress cake formation at high concentrations and throughput, including surface
roughness, inertial lift, pulsatile (unsteady) flows, and Dean flows [87]. Unfortunately, these
schemes cannot be easily applied to selective separation, since the enhanced local shear could
also remove captured target cells. In this thesis, an in depth discussion on the machanisms
responsible for stagnant layer formation, its impact on specific cell capture and modification of
spatially modulated microflows that restore optimal functioning are discussed in this thesis.
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2.6 Summary
In this chapter we discuss the importance of cell separation and its myriad applications in
biomedical engineering and biology. We discuss various macro- and microtechnology tools
currently available for separating out cells based on physical, electrical and biochemical
properties and emphasize the advantages and disadvantages of each. Given the focus of this
thesis and specificity of cell separation based on molecular recognition we dive deeper into the
limitations of the current solid surfaces microfluidic devices that seek to leverage this property
for cell separation. Broadly, solid surface microfluidic devices do not offer high sample
processing throughput thereby limiting practical applications for applications where large
volume of sample requires processing. Consequently, we introduce the previous use of porous
surfaces in microfluidic devices and discuss the limitations, mostly attributed to the formation of
stagnant layers which decrease device performance over a large period of time. Together,
introduction to all these concepts set up the motivation for this thesis " Nanoporous Surfaces
Enable High Throughput Specific Cell Capture".
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Chapter 3
Integration and characterization of
nanoporous membranes in microfluidic
devices
In this chapter, we describe the integration and characterization methodology used for
incorporating commercially available nano-porous surfaces into the micro-fluidic devices.
Methods to sandwich porous surfaces in microfluidic devices have previously been described
and since the primary objective of this thesis is to process samples at high flow rates, we
optimize one of the existing fabrication strategies to insure device integrity in section 3.1.
Additionally, in Section 3.2 we investigate different known functionalization strategies for
porous surfaces. In section 3.3 we optimize the pore sizes needed to achieve enhanced mass
transport and surface interactions of cells with the surface without physical trapping of cells
within the pores. In section 3.4, we develop a lumped resistance model for the two-layered
porous surface device which describes the use of high external resistances. Lastly, in section 3.5
we use the lumped resistor model developed in Section 3.6 to perform permeability experiments
and measure fluid flux through the porous surface as a function of pressure. This model is the
mainstay of replicating capture efficiency results, even in the presence of porous surface
variations in commercially available membranes.
3.1 Integration of porous membranes in microfluidic devices
Integrating porous membranes in microfluidic devices has been of significant interest over the
past decade due to the diversity of applications described in section 2.5. Many different
approaches have been reported to integrate membranes in microfluidics. They can broadly be
classified into four categories: (1) In-situ preparation of membranes [88, 89] (2) membrane
preparation as a part of the chip fabrication process [90, 91] (3) Use of membrane properties of
the bulk material [92] (4) Direct incorporation of the commercial membranes [82, 93, 94]. Due to
the availability of a large number of specified parameters (pore size, membrane thickness) and
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range of membrane in commercial membranes, direct incorporation using clamping or gluing has
become an attractive option.
The microfluidic channels are fabricated using soft lithography technique [95]. Briefly, the
PDMS prepolymer (Sylgard 184, Dow Coming NY) was mixed with the curing agent in a weight
ratio of 10 (pre-polymer): 1 (curing agent). The mixture was cast onto a 4 in. silicon wafer with
positive relief features with a height of 10Opm and cured at 60*C. The cured PDMS was peeled
from the silicon wafer and holes were punched at the inlets and outlets of the device (Fig. 3-1).
Uncured PDMS mortar is used to bond the PDMS Channels and the membrane together. To
create the PDMS mortar layers, PDMS and toluene were mixed at predetermined mass ratios and
the mixture was de-gassed in a vacuum chamber to remove any bubbles. The toluene-diluted
PDMS mortar was spun onto the glass cover slides at 1500 rpm for 1 min. The PDMS devices
channels were stamped onto the spun uncured PDMS mortar and pressed gently for 2 min. The
membranes (GE-Whatman, CT) were cut to the desired dimensions, placed gently over the
bottom microfluidic channel and straightened out carefully using tweezers. Because the dimesion
of the porous surface area is defined by the overlap of the top channel and the bottom channel,
the top channel is carefully aligned under a microscope for precise alignment. The construct is
left overnight in the oven at 70*C.
(a)(b) (c)
De-gas and spin uncured
PDMS mortar PDMS mortar transfer Alignment
(d) (e) (f)
Compression PDMS curing
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Fig. 3-1 (a) Negative photoresist (SU-8, MicroChem) was photolithographically patterned on
silicon wafers to create masters. The masters were then used as molds, on which
polydimethylsiloxane (PDMS) prepolymer mixed with its crosslinker at 10: 1 weight ratio was
poured, degassed, and allowed to cure in a conventional oven at 65 *C for 24 h before removal
from the molds. Next, a thin layer of uncured PDMS diluted in toluene (50% v/v) was spun 1800
rpm for 1 min onto a glass slide using a high-speed spinner. (b) The thin layer of PDMS was
transferred onto the channel surfaces by gently stamping the PDMS channel onto the uncured
PDMS. (c) The polycarbonate membrane was gently placed over the bottom channel first and
then the top channel was carefully aligned over it. (d) Gentle compression applied using a clamp
(e) The device constructs was allowed to sit at room temperature overnight to cure at 70'C. (f)
Exploded view of the porous surface device with dimensions
3.1.1 Uncured PDMS binding mortar thickness optimization
For successful integration of the membrane and sealing of the construct that can withstand large
pressures, it is important to optimize the thickness of the uncured bonding PDMS mortar
transferred to the surface of the PDMS channels in. Unless care is taken, air pockets can form at
the edges of the membrane when the membrane is sandwiched between the two PDMS pieces
and compromise the pressure that the device can withstand. Specifically, the combined PDMS
mortar thickness on the upper and lower PDMS pieces should be sufficient to penetrate through
the pores and form a stable bond, yet not too thick to flow into the channels. Additionally, it is
important that the mortar thickness transferred to each of the cured PDMS channels should be at
least the height of the membrane (~ 10 pm). The thickness of the mortar transferred can be
changed by varying the spin speed. As seen in Fig. 3-2, for a given spin speed, the thickness of
the mortar transferred decreases as the spin speed increases and saturates at ~ 3 pim above 2500
rpm for PDMS : Toluene ratio of 1:1 by mass. This saturation thickness is reached earlier ( 1500
rpm) for PDMS : Toluene ratio of 1:2. Thickness of the PDMS mortar transferred was measured
by making a cut was through the cured PDMS mortar and the original PDMS channel slab. This
construct was then visualized under an inverted microscope with a 40 X objective (Nikon TIE).
The measurements were calibrated by using a reference of a known thickness.
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Fig. 3-2 PDMS mortar thickness transferred to the PDMS slabs as a function of spin speed
3.1.2 Device strength characterization
To measure the burst strength of different mortar thicknesses, the channels were filled with
Fluroscien Isothiocynate (FITC) dye and the top channel outlet and the bottom channel inlet
were clamped. The dye solution was introduced into the top channel though the top inlet using a
constant pressure pump and was allowed to pass through the membrane and exit through the
bottom outlet. For each mortar thickness, the input pressure was increased in steps and the
channel was viewed under the microscope till FITC starting leaking out of the boundaries
defined by the top and bottom channels. The burst pressure increases with the increase in
uncured mortar thickness transferred (Fig. 3-3), due to more stable bond formation across the
membrane, and saturates at mortar transfer ~ 15 pim (burst strength ~ 350 Kpa). The saturation
pressure is reached due to the physical limit of cured PDMS bond strength [96].
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Fig. 3-3 Pressure at which the porous surface sandwiched device leaks as a function of the
mortar thickness transferred.
3.2 In-situ functionalization of nanoporous membranes incorporated in
microfluidic devices for specific biorecognition
Functionalization of porous surfaces such as carbon nonotube forests, monoliths and
commercially available membranes for specific bio-particle recognition has been investigated
widely in the past (see section 2.2). Due to the commercial availability and ease of integration of
nanoporous membranes, we focus on the covalent and non-covalent functionalization strategies
developed for nonoporous membranes. Our goal in this section was to select an effective on chip
specific functionalization strategy that does not compromise the device integrity while blocking
non-specific binding on nanoporous membranes.
The most common non-covalent functionalization strategy involves physical adsorption of the
proteins onto the nanoporous surface through hydrophobic interactions. Surface coverage of
proteins on the hydrophobic surfaces has been characterized using atomic force microscopy.
Covalent attachment of proteins onto any surface, on the other hand, requires formation of
functional groups, which is conjugated to the desired protein via a linker. Such covalent
attachment is a function of a chemical bond between the surface and protein which prevents
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desorption from the surface even under shear from the fluid. Polycarbonate membranes can
either be activated using ionic plasma [97, 98] or chemical methods. However, once integrated
into the microfluidic device, ionic plasma does not effectively penetrate into the microfluidic
channel to activate the porous polycarbonate surface. Additionally, if the polycarbonate
membrane is plasma activated before integrating into the device, extreme caution is required to
not contaminate the surface. Instead, chemical methods provide a comfortable and reliable way
for in-situ activation and functionalization. Previously, amino-containing ligands have been
bound to the activated carbonates on the hydroxyl groups of the polysaccharide support such as
agar and dextran for affinity chromatography [99]. A similar approach for polycarbonate
membranes is to couple poly-(L-lysine) to polycarbonate membrane on the activated carbonate
groups of the polycarbonate membrane and activate the other amino groups of poly-(L-lysine) by
addition of glutaraldehyde [100]. This is followed by incubation of the protein of interest which
attaches to the the aine groups. Schematic of the different reactions during these steps are shown
in Fig. 3-4a. Specifically, after integrating the membrane into the microfluidic device (see
section 3.1), a 20 mg of poly-(L-lysine) was dissolved in 1.0 mL of 50 mM sodium carbonate
solution was prepared and was flown into the microfluidic device at 5 p1/min and kept at 4'C for
24 h. The membrane was then thoroughly washed with distilled water. In order to immobilize
protein, the polycarbonate membrane immobilized with poly-(L-lysine) was soaked in 50 mM
phosphate buffer, pH 7.0, containing glutaraldehyde (1.0% v/v) for 2h at 4"C. Then the
membrane was washed several times with distilled water and phosphate buffer. Avidin
(50ptg/mL) was then flown into the microfluidic chamber and was allowed to sit for 24 hr. In
order to reduce the non-specific binding, Tween-20, an ampiphyllic molecule was added which
covered the uncoated regions of the polycarbonate membranes. Hydrophobic interactions
between tween and the polycarbonate lead to non-covalent coverage between the covalent
linkages of polycarbonate membrane and the protein.
In order to measure the effectiveness of the covalent method of functionalization over the non-
covalent adsorption, avidin protein surface functionalization was tested by using complementary
fluorescent biotin for specific binding and using fluorescent bovine serum albumin for non
specific binding. Fluorescence measurements across the channel width showed a two-fold
increase in avidin functionalization using covalent lysine activation of the polycarbonate
membrane compared to the adsorption (Fig. 3-4b). A 2.5 fold increase in the fluorescent biotin
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signal was seen for functionalization of the polycarbonate microporous surfaces for the lysine
activation method over the regular physic-sorption (Fig. 3-4 b,c,d)
A o o1> B - Lysine activation
- adsorption
Poly-Lysine 0.6
(100mM, 24h, 4C)
C0- S 0.4]
Glutaraldehyde NH 0.0(50mM, 2h, 4C) Channel Edge Center Channel Edge
C=o
Porous Surface Lysine Activation Porous Surface adsorption
OHC-(H)-H c c1cagcH
Avidin
(50 sg/mL)
-- C. MCHI) c
Biotin-EpcAM c c.-o
(100 pg/mL) AVi d i n - N %kcc~,CmcHz)cH9
I . 1
Biotin-EpcAM
Fig. 3-4 (A) Poly-(L-lysine) functionalization protocol (B) Intensity measurement across the
channel for Lysine activated avidin functionalization and adsorption based functionalization (C)
representative image for the lysine activated channel (D) representative image for the adsorption
channel
3.3 Lumped resistor model
The microfluidic device fabricated in section 3.2 can be represented as shown in Fig. 3-5. The
figure shows the important independent and dependent parameters of consideration that define
the system completely. The independent variables include the geometrical parameters of the top
and bottom channel (L = length of the channel, w = width of the channel, hi = height of the top
channel, h2 = height of the bottom channel), the membrane (porosity as function of pore diameter
(d,) and pore frequency (fp)) and the set pressure at the inlet (Pset) and the outlet (PO). These
independent variables are responsible for driving dependent variables such as the fluid flux
through the top (Qt) and the bottom channel (Qb), which are of critical interest for the remainder
of this work. As shown in Fig. 3-5, several independent variables dictate the fluid flux and
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changing either of these can change the fluid dynamics of the entire system, making it hard to
predict the flux components. Instead, another way to describe the model would be to lump the
geometrical components into their corresponding elemental resistances. The corresponding
elemental resistances and the model are shown in Fig. 3-6a.
Inlet Outlet
Tet ,1 wi
L
Dependent vanables Independent variables
Fig. 3-5 Schematic showing the independent and dependent variables in the integrated
nanoporous surface device
A consequence of the lumped resistance model is that the fluid flux through the top and the
bottom outlets of the device remain same as long as the components resistances of the device
match. This allows fabrication of equivalent devices with different dimensions and geometries.
The lumped resistor model also allows us to overcome the variability in the commercial
membrane porosities and membrane resistances. By adding large resistive tubings at the top and
bottom outlets, we can "short" or remove the dependence on the variable commerical membrane
resistance (Fig. 3-6b). Eqn. 3.8 describes the criterion under which this "shorting" condition
would take place.
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Fig. 3-6 Lumped resistance model (a) Element resistances (b) Lumped resistor model
Fig. 3-6b shows the lumped resister model for the sandwiched nanoporous membrane device.
Using high resistive elements at the end (RO,T and RO,B) percentage permeation flux (A)
variations can be reduced. These output resistive elements can either be fabricated on the
microfluidic chip as channels or can be externally added in the form of tubings. Large resistive
tubings (tubing radius, rt=50 jim) at the top and bottom channels helped "short" out any inherent
variations in the commercially available membranes and insure constant permeation flux along
the length of the membrane. The ratio of the resistances of the top and bottom tubings determine
the fluid split, whereas the actual resistances of the tubings determine the sample flow rate
through the top and bottom outlets of the channels. The different component fluidic resistances
of the device are shown in Table 3.1. The channel resistances (Rch) were calculated using Eqn.
3.1
R 12pLh (3.1)ch wh 3
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The tubing resistances (Rtubing) were calculated using Eqn. 3.2
R 8 pLtRuing , 4
The membrane resistances (Rn) were calculated using Eqn. 3.3
8p8 i, 1R,, 4 .- *7zr n
Based on the above resistances, the theoretical flow rates in the top channel (Q,) and through the
membrane and out of the bottom outlet (Qb) are given by
RbP
in(Rf(R, +R,)+RR,)
RbP
(Rh(Rh +R,)+RbR,)
Where,
The resistance of the top arm of the device is given by
RI = RchT + Ro,T
and, the resistance of the bottom arm is given by
Rb = R, + Rch,B+ Ro,B
If,
RO'T >10*Rehr
ROB >10*(R, +Rch,B
Then, the resistance in the top arm (Rt) is dictated solely by the external top outlet resistance
(Ro,1)
R, = R 1  (
and the resistance in the bottom arm (Rb) is dictated by the external bottom outlet resistance
(Ro,B)
Rb = R B
(3.4)
(3.5)
(3.6)
(3.7)
(3.8)
3.9)
3.10)
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(3.2)
(3.3)1
Combining 3.4,3.5,3.9 and 3.10, we find that the fractional permeation flux through the
membrane (A) is given by 3.11 and is also dependent on externally controllable resistances.
A= Q - R, (3.11)
Q, + Q -R,+ Rh
The resistance values in Table 3.1 show that the output tubings have resistance much greater
(-10 times) than the fluidic resistance of the channel or the membrane. Under this condition, the
resistance model can be simplified as shown in Fig. 3-6b. The effect of the simplified model is to
maintain a constant pressure difference along the length of the membrane. Since pressure
difference drives fluid flow, a constant uniform velocity of fluid flux at the wall is expected. In
contrast the previous models described have a diminishing wall velocity do to a decrease in
pressure towards the end of the channel.
From Eqn. 3.11 we see that addition of high resistances at the end of the channel leads to the
dependence of the fraction permeation flux, A, completely on the lengths of the resistive
elements at the outlets. Additionally, the simplified model allows prediction of the fluid split and
flow rates based on the lengths and therefore the resistances of the outlet tubings. Eqn. 3.6-3.11,
define sample fluid flow rate through the top channel and the membrane depends on the absolute
values of the top and bottom output tubing resistances, but the split depends on the ratios of the
two.
Inlet Top Top Outlet Bottom Bottom Membrane
tubing Channel tubing Channel outlet
tubing (Average
(Length= (Length = porosity - 10%,
50 cm) 266 cm) (Length= rp = 100 nm)
114 cm)
Fluidic 4.9xl 12 1.24x10" 2.6 x10" 1.5x10 1.1x10 13  1012
Resistance
Table 3-1 Component resistances of the device. The tubing resistances are kept at a much higher
resistance that the channel and the membrane resistances.
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3.5 Fluid flux measurements
In order to measure the fluid flux through the top channel and the bottom channel, we used a
constant pressure source and control the outlet resistances (ROT and RO,B) by externally changing
the lengths of the tubing's. The resistances of the tubing's were calculated using Eqn. 3.2. The
fluid was collected into eppendorf tubes out of the top and bottom inlets at each pressure value
and the collected volumes were measured. These experimentally measured volumes were
compared against the theoretical values using Eqn. 3.4, Eqn. 3.5, Eqn. 3.9 and Eqn. 3.10 of the
lumped resistor model (See section 3.4). We find that there is precise agreement between the
theoretical and experimental results as the flow rates through top and bottom channels scale
linearly with applied pressure difference (Fig. 3-7a). Moreover, the ratio of flow rates in the top
and bottom channels is constant, governed by the high resistance outputs. The model was able to
accurately predict the fluid split between the top and the bottom channels as a function of the
sample input pressure when the tubing resistances were approximately ten times the fluidic
resistance of the membrane and the channels in a sample with dilute suspension of particles (<o <
0.1). In the event when the outlet tubings are short in length and the criterion of Eqn. 3.8 is not
met, the flux through the top and the bottom channels varies greatly. A mean standard deviation
of 0.42 ml/hr permeation flux through the membranes was measured due to porosity differences
in the polycarbonate membranes (Fig. 3-7b).
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Fig. 3-7 (a) Experimental and theoretical flow rates through the top and bottom outlets of the
device and the ratio of the top flow rate to bottom flow rate as a function of pressure with no
external resistances (b) Experimental and theoretical flow rates through the top and bottom
outlets of the device and the ratio of the top flow rate to bottom flow rate as a function of
pressure with external resistances
3.6 Summary
In this chapter, we described and optimized the integration and characterization methodology
used for incorporating commercially available nano-porous surfaces into the micro-fluidic
devices. Additionally, using fluorescence as the read out we showed that covalent
functionalization of proteins on polycarbonate surface is more effective compared to physic-
sorption. Further, in the section we develop lumped resistor model which helped us reproducibly
control the fluid flux through the top and bottom channels by appropriate selection of large
resistances at the outlet. This model remains the mainstay for the rest of the thesis as it is critical
to precisely control the fluid fluxes through the top and bottom channels. Finally, we
demonstrated agreement between the expected permeation flux and flow rates through the porous
surface using the lumped resistor model and the experimental results
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Chapter 4
Antibody-Functionalized Fluid-Permeable
Nano-Porous Surfaces for Rolling Cell
Capture at High Flow Rates
Introduction
In this chapter we describe the use of fluid permeable nano-porous membranous surface
microfluidic device towards capturing specific target cells (PC3, PC3-9 and H1650) at high flow
rates. In section 4.1 we describe cell sample preparation, device operation and cell quantitation
methods used in every experiment. Section 4.2 elucidates the role of fluid permeable surfaces to
enhance mass transport from the lumen of the microfluidic device to the antibody covered
reactive porous surface. In this section we model fluid and cell streamlines and compare the
results quantitatively to the cell trajectories observed in a solid surface and a porous surface
microfluidic device. Additionally, using fluoresce microscopy we measure the fraction of the
total cells that convect to porous surface as a function of the permeation flux (A). Once the cells
are on the surface, we study the rolling motion of cells in section 4.3. Section 4.4 explores the
effect on the cell surface average velocity along the channel length and compares it with the
hydrodynamic model developed for the solid surface in section 4.5. In section 4.6, we look at the
cell motion in more detail by evaluating the motion of individual cells on the porous surface as a
function of time. Studies in section 4.4 and 4.6 are used as inputs to model the probability of cell
capture at a function of cell surface velocity in section 4.7. Section 4.8 describes the amount of
force associated with breaking a single EpCAM antigen/anti-EpCAM bond and extrapolation
into dislodging non-specific cells, while retaining specific cells. In section 4.9 we look at the cell
capture efficiency of low expressing prostate cancer (PC3-9 cells), and high expressing prostate
cancer (PC3) and lung cancer (H1650) cell lines as a function of flow rate on a porous and solid
surfaces, covered with specific anti-EpCAM antibodies and non-specific IgG antibodies. We
summarize the findings in section 4.10.
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4.1 Methods
In this section we describe the methods used for cell sample preparation, device operation and
target cell enumeration. These methods are followed for all the experiments performed in chapter
4 and chapter 5.
4.1.1 Cell sample preparation
Leukocytes ("buffy coat") used in the experiments in chapters 4 and 5 were isolated from whole
blood using deterministic lateral displacement [101] and resuspended to the relevant
concentration. The sample concentration (Cceis) of 500,000 cells/mL corresponded to a volume
particle fraction (#0-0.01). Subsequently, Cceiis~1.5x106 cells/mL correspond to o-0.03 and
Cceis~2.5x106 cells/mL correspond to 0-0.05. These cells were fluorescently labeled (Cell
Tracker Calcein green, Invitrogen, Carlsbad, CA) following the manufacturer protocol. PC3
human prostate cancer cells (ATCC), PC3-9 and H1650 cancer cells lines used were cultured at
370C and 5% C02 in F-12K growth media containing 1.5 mM L-glutamine supplemented with
10% FBS and 1% Penicillin/Streptomycin, with media changes every 2-3 days. These cells were
labeled with a different fluorescent dye (Cell Tracker Orange, Invitrogen, Carlsbad, CA) and
spiked into the sample at a ratio of 1:250 (2000/mL). The PC3, PC3-9 and H1650 cell spike
count was verified immediately before addition to the buffy coat population as well as before
loading the sample into the device. These readings were consistent within 5%.
4.1.2 Device Operation
As mentioned in section 2.4, immuno-chromatography based cell separation have two steps.
First step is the capture phase, in which the sample is flown through the device as a desired flow
rate that allows specific cell capture. In the second step or the wash phase, buffer solution is
flown through the device to remove non-specifically bound cells to surface. During the wash
phase, shear force differential between the specific cells and non specific cells be optimized such
that only the non-specific cells get pulled off from the surface during the wash step.
In case of nano-porous surface integrated device the capture phase requires injection of the
sample through the top inlet, keeping the top outlet and bottom outlet open (Fig. 4-1 al). In this
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configuration the streamlines get biased towards the nano-porous surface due to fluid permeation
through it. As the size of the pores is in the nanometer range (radius = 100 nm) cells in the input
sample do not pass through the pores but follow the streamline and come in contact with the
reactive surface. One at the surface, the shear in the microfluidic device leads to cell rolling and
allows interaction between the complentary receptor-ligand (fig. 4-1a2). The forces that dictate
this configuration are described in more detail in section's 4.4 and 4.5. During the wash step, the
bottom outlet is closed by clamping the tubing and the top outlet is kept open and buffer is
injected into the microfluidic device. In this configuration, no fluid permeates through the nano-
porous membrane and the device has similar fluid dynamics to a regular solid surface channel
(Fig. 4-1b).
Experimentally, samples were loaded into a 60 mL syringe and a constant pressure syringe pump
was used to apply a constant flow through the top inlet, while the bottom inlet was closed. The
top and bottom outlets were both open, and the ratio of transverse membrane flux and axial
channel flux was regulated using relative resistances of the outlet tubing (see section 3.3). After
the sample had been processed, the bottom outlet was closed and PBS was flowed through the
top channel to remove nonspecifically bound cells.
al
a2
b
Fig. 4-1 (al) Cell capture mode with the top outlet and the bottom outlet open. In this stage the
cells get convected to the surface (a2) The top and the bottom outlet remain open, however, this
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phase focuses on the translational motion of cells along the cell surface. (b) The top outlet
remains open, but the bottom outlet is closed and buffer is flow throw the top to wash the non
specific cells.
4.1.3 Imaging and quantitation of specific cell capture
Cell capture was visualized using an upright epifluorescence microscope (Nikon Eclipse 90i)
using a 4X (Nikon Plan Fluor, NA=0.13) or 10X objective (Nikon CFI Plan Apo, NA=0.45) at
10 frames per second with a CCD camera (Qlmaging Retiga 2000R). Overall cell capture in the
device (Nc) and waste collection (Nout) were enumerated using three different emission spectra to
identify cells (DAPI) as well as distinguish spiked PC3 cells (CTO) and background leukocytes
(FITC). The capture efficiency was calculated as the captured cells divided by the total cells
flowed through the device, i.e. Nc/(Ne+Nout) averaged over three experiments. Mass balance on
the number of PC3 cells spiked into the cells was performed by counting the number of cells
injected into the device, the number of cells captured on the porous membrane and the PC3 cells
that exited the device into the collection well. There was a -4% difference between the intended
number of cells injected into the device and the number of cells that was accounted for using
mass balance.
4.2 Cell Transport to Surface is Enhanced by Diverting Streamlines
As discussed previously, the effectiveness of conventional adhesion-based assays is strongly
diminished at high flow rates since most cells do not reach the surface. To overcome this
limitation and enhance cell-surface interaction, in this thesis we develop a two-chamber
microfluidic device was developed, with a porous capture surface sandwiched in between (Fig.
3-1). These surfaces consisted of commercially available polycarbonate membranes with an
overall porosity of 10% and average pore diameter of -200 nm, which allow fluid permeation
but are small enough to prevent the -10 ptm cells from entering or becoming trapped. This device
geometry allows a controlled fraction of the incoming fluid flow to be diverted into the porous
membrane, while the remainder continues to the outlet. These fluid flow conditions were
calibrated and in good agreement with the expected values based on the applied pressure
difference (Fig. 3-7b).
57
4.2.1 Fluid streamlines in a porous surface device
The limiting case of no fluid flux through the membrane is essentially equivalent to flow past a
solid surface, since all the fluid flux is exiting through the top outlet. The cell trajectories in this
scenario are well described by pressure-driven Poiseulle flow in the axial direction, as well as a
constant sedimentation velocity due to the density difference of the cells [102]. The non-
dimensionalized axial and transverse fluid velocity field components Ux, Uy as a function of
(non-dimensionalized) coordinate system (X= x/h, Y = y/h), are given by:
Ux (X, Y)= 6 (Y -Y 2); Uy (X, Y)= 0 (4.1)
In order to derive, fluid streamlines from the existing velocity fields for a solid channel, we use
non-dimensionalized coordinates for coordinates xy; pressure p, velocity ux and ratio of
permeation flux to total flux A
X Y < P > , < U > VW
p09Y _9 <U 0  <U >x>Ah h PO  uO > < uO > (4.2)
Further, since the channel has a small height compared to its length and Reynolds number is low
(Re << 1), lubrication approximation holds
o5u h dP
-fy =--, BC's: u (X,0)=ur(X,l)=0 (4.3)
H2 p dX (' =UM =0
Considering an elemental section in a microfluidic device with a porous bottom surface, the fluid
balance is given by relating the average fluid velocity along the length of the channel to the fluid
permeating through the membrane,
d < u_ > VW (44)
dX h
Integrating along the length of the channel,
< ux >= uO(1 - vX (4.5)
Therefore,
ux(X,Y) = 6u0(I - v,X)(Y - Y2) (4.6)
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In its non-dimensional form,
Ux (XY) =6(1 - AX)(Y - Y 2) (4.7)
The transverse fluid velocity field u,(X,Y), can be obtained from the continuity equation
X + =0 (4.8)
Integrating Eqn. 4.18,
uY(X,Y)= - (X,S)dS, BC: u,(X,1)=0 (4.9)
Y 9X
uy(XY) = -v,(2Y3 - 3Y2) (4.10)
Where v, is the superficial wall velocity at the porous surface,
_ Q AP AP (4.11)
Ame A,,(Rm + Rh) (w * L)(R,, + ROb)
In non-dimensionalized form,
U,(X,Y) = -A(2Y 3 - 3Y 2 ) (4.12)
The y-component of the fluid field is responsible for rapid advection of cells traveling along
streamlines to the capture surface. Therefore, for the fractional permeation flux through the
membrane A, the non-dimensionalized velocity field components are given by:
Ux (X,Y) = 6(1 - AX)(Y - Y); U, (X,Y)= -A(2Y - 3Y) (4.13)
The corresponding fluid streamlines in the rectangular channel with a porous bottom is therefore
given by,
3Y2 -2Y 3 = " "2Y§ (4.14)
1+ AX
Since the no permeation case is similar to a solid surface case and is a limiting case of the
permeation fluid fields derived in Eqn. 4.13, we should be able to retrieve results for the solid
surface fluid fields by inserting v,~ 0 in Eqn. 4.13.
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4.2.2 Cell trajectories in a dilute suspension
Even in a solid surface microfluidic device, the constant cell sedimentation perturbs the cell
trajectories slightly from the fluid streamlines due to the density difference between the cell and
the surrounding mediaThe corresponding cell velocities in the x- and the y- directions are given
by
Ux (X, Y)= 6 (Y - 22); Uy (X, )= -B (4.15)
where B = 2R 2gAp/9po ~ 2 pim/s, is a constant sedimentation velocity for a particle of radius Re
= 5 pm and density difference Ap ~ 0.030 g/cm 3 (with respect to the solution).
To calculate the cell velocities in the porous surface device we use Faxen's law, which provides
a general relationship between force on a spherical cell (F), its velocity (up) and the unperturbed
fluid velocity (u,) field far from the particle center. To determine how the cell trajectory is
affected by the fluid streamlines, the x- and y- component of Faxen's first law for a non-buoyant
cell (density difference Ap=0.030 g/cm 3) were calculated:
R 2
F F, - 0 = 61pR, {(u), -(u ), + c (V 2 (u),}} (4.16)
4xR'Ap R 2
F,,~ F, ~ C 6zpR, {(u), - (u,), + "c (V2 (u),) (4.17)eI 3 6
where R, = radius of the cell (5 tm). The effect of cell radius on streamline trajectory is
negligible for Rc< 20ptm. Therefore higher order R, terms in Eqn. 4-15 and Eqn. 4.16 can be
neglected and the Faxen's first law can be re-written as:
F ~ 0 = 6pR, {{u), - (u,), (4.18)
4;rR'?Ap
F, ~ 3 = 6xpRc{(u), - (uP),} (4.19)
The particle trajectory is thus given by,
dy v,(3Y2 -2Y')-B (4.20)
dx 6<u,>(1-vX)(Y 
-Y 2)
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The cell trajectory in the solid surface microfluidic channel can be obtained by setting v, - 0 in
Eqn. 4.20
A representative case is shown in Fig. 4-2a for a cell sedimentation velocity of 2 pm/s and an
average flow velocity of <Ux> = 10,000 tm/s, corresponding to a flow rate Qin = 6 mL/hr and
cell radius Re = 5 pm. At these high flow rates, cells are advected through the device so rapidly
that they have very little time to sediment. Based on the calculated cell trajectories for these
conditions, only those cells that are initially near the bottom of the channel (y < 10 pm) can reach
the capture surface. Assuming that cells are uniformly distributed at the 100 pm high entrance,
this corresponds to ~10% of cells reaching the surface, while the remaining -90% have no
opportunity to interact with the surface and get captured. These calculations are consistent with
experimental measurements of the cell trajectories under these flow conditions using
fluorescence microscopy, which show cells moving rapidly with constant axial velocity
throughout the 3,000 pm field of view (Fig. 4-2c).
As the fluid permeation flux through the membrane is increased, more and more of the
streamlines are diverted from the top outlet to the porous membrane (Fig. 4-2b). The calculated
cell trajectories for this scenario are illustrated for a representative case of 70% permeation flux
through the membrane, but the same flow rate as the previous example (Qin = 6 mL/hr). In this
case, the calculated cell trajectories do not deviate significantly from the streamlines (<1%),
since advection (10,000 ptm/s) dominates over sedimentation (-2 pm/s) and hydrodynamic
effects. These calculations are corroborated by experimental measurements of the cell
trajectories (Fig.4-2d), showing that the axial velocity Ux rapidly decreases from an initial value
of 2000 pm/s at x = 2.4 cm to -200 um/s at x = 2.7 cm as the cell is transported to the surface
and the transverse velocity Uy becomes more significant. Due to the device geometry and the
rapid axial velocity of the cell, it is difficult to directly measure the height of the cell during its
trajectory. However, a qualitative comparison of the calculated cell trajectories (Fig. 4-2b) with
the experimentally measured cell axial velocities (Fig. 4-2d) suggest that these cells entered the
device at a height roughly halfway between the bottom and top. Based on the calculated
streamlines, all cells that enter the channel within 70 ptm of the bottom surface should be
captured (-70%), whereas the remaining 30% of cells exit the device at the top outlet.
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Fig. 4-2 Theoretical particle trajectories (dashed black lines) and fluid velocity field vectors
(color) in channels with (A) solid surface (A = 0%) (B) fluid-permeable surface (A = 70%).
Color bar corresponds to the magnitude of fluid velocity vectors. Experimentally measured
particle velocities tracked in channels with (C) solid surface (A = 0%) and (D) fluid-permeable
surface (A = 70%).
Streamline analysis predicts that if cells are uniformly distributed at the channel entrance the
percentage cells convected to the porous surface from the bulk at high flow rates should be the
same as the percentage of fluid permeating the porous surface. This was corroborated
experimentally by visualizing fluorescently labeled cells under a microscope. The microscope
was focused at the porous surface at the end of the channel and videos for each permeation flux
condition were recorded. Cells "rolling" on the surface were focused and had round morphology,
compared to the cells in the bulk which appeared as streaks. The length of the streak was a
function of the velocity of the cell in the channel and the exposure time through the fluorescence
shutter. Enumeration of the cells showed that the total fraction of cells transported to the porous
capture surface scales linearly with the percentage of the fluid flux into the membrane (Fig. 4-3).
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Fig. 4-3 Percentage cells convected to a porous capture surface scales linearly with the
percentage permeation flux. Each data point corresponds to measurements on 5 independent
devices, with pore size rp=100 nm.
4.3 Cell convected to the porous surface portray a rolling motion
In order to discern the motion of cells convected to the surface, we used asymmetrically
fluorescent Janus particles and viewed the particles under high magnification (40X). The Janus
particles were partially sputtered with gold which blocked the fluorescence from the particle.
Under the microscope we were able to see the sequential change in fluorescence position as the
particles moved along the length of the channel indicating rolling motion.
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Fig. 4.4 Sequential images of gold coated Janus particles indicating rolling motion on the
surface.
4.4 Nano-porous fluid permeable surfaces decrease surface rolling
velocity
An important implication of the streamline calculation is that when permeation occurs, the axial
fluid velocity Ux decreases linearly along the length of the device. At each position, x, along the
length of the channel, a certain fraction of fluid permeated through the surface. As a result, the
shear rate near the surface is also expected to decrease with increasing distance x, reaching a
minimum at the end of the porous surface. Since the shear in the bulk is responsible for
translation motion of the cell along the porous surface, we expected a decrease in the cell surface
velocity. To verify this trend, the cell surface velocity uc(x) was experimentally measured at
three locations (beginning, middle and end) along the length of the device for various values of A
at a constant flow rate (Qin = 6 mL/hr) and fit using linear regression (Fig. 4-5). The cell velocity
decrease over the length of the channel is linear. This is owed to the presence of large external
resistances at the channel outlets that maintain a constant permeation flux throughout the length
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of the channel. As a result the decrease in the shear and hence the velocity per unit length is
constant. To understand the effect of the magnitude of fluid permeable nano-porous surface on
cell velocity, these measurements were compared to the limiting case of cell motion along a solid
surface at the same bulk shear using the hydrodynamic model proposed by Goldman et al. for a
particle moving near a solid surface due to a shear field [103]. Experimentally using the
following scaling for cell surface velocity:
uc(x) ~ uc,o(1 - Ax / L) (4-21)
where uc,o is the cell surface velocity at the entrance and L is the channel length. The measured
velocities and Goldman model show good agreement for A = 50% (Fig. 4-5). However, at larger
permeation fluxes, the experimental cell surface velocities are consistently slower than the
expected values by several hundred microns per second.
4.5 Comparison of measured cell surface velocity on the porous surface
with hydrodynamic Model
The hydrodynamics of a particle moving near a solid surface due to a shear field were previously
treated theoretically by Goldman et al. [104]. Based on the total flow rate of 6 mL/h in a channel
with dimensions with L=4cm, w-2mm and h=100 [tm through the channels, there should be a
shear stress of 5 dyn/cm 2 at the entrance. Assuming a particle-surface separation of 50 nm [105],
the initial cell surface velocity is expected to be uc,o= 1000 pim/s. This value is incorporated into
a phenomenological equation based on Eqn. 4-20: uc(x) ~ uc,o(1 - Ax / L). As shown in Fig. 4-4,
the measured velocities are consistent with the hydrodynamic model at A = 50%. However, the
measured values are significantly slower than those predicted from the model and increasingly
deviate at higher permeation rates. This discrepancy arises from the porosity of the surface,
which is not accounted for in the Goldman model. The slowdown accounts from an additional
"suction" force that causes temporary pauses in cell motion. This suggests that the cell surface
velocity is not solely dictated by the local shear field, but may have additional inhibitory
interactions with a porous surface that do not occur on a solid surface. These cell-surface
interactions pauses are examined in more detail in the subsequent section.
65
II I I I
E 1000- Measured
- Best-Fit Linear Regression
800- ' . Hydrodynamic Model (Goldman et al)
0 600- A. 50%
400- * A =60%
200-
0- A =80%
U%. I I I I I
0 1 2 3 4
Channel Distance (cm)
Fig. 4-5 Comparison of measured cell surface velocity (markers), best-fit linear regression (solid
lines) and hydrodynamic model of Goldman et al (dotted lines). Measured values are in
agreement with model for A = 50%, but are consistently slower at larger permeation.
4.6 Cell-surface interactions are promoted by a fluid permeable surface
In the previous sections we have quantified cell convection to the reactive porous surface and the
characteristics of cell rolling on it. The effectiveness of cell capture assays also depends on the
arrest of cell motion on the surface, which occurs through the competition of specific
biomolecular bond formation and local shearing forces. A mathematical model built elucidates
this in more detail in section 4.7 and section 4.8. Near a surface, cells have been previously
observed to "roll" at constant velocity due to hydrodynamic interactions, which is essential for
selective capture both in vitro and in vivo. Representative individual cell trajectories were
examined near a porous surface functionalized with non-complementary IgG antibodies (Fig. 4-
6a). Up until time t = 1 s, the measured axial velocity Ux rapidly decreases as the cell approaches
the surface, after which it maintains a reduced, constant velocity (Fig. 4-6b). Since the IgG
antibodies cannot form strong specific biomolecular bonds with the cellular receptors, motion is
never completely arrested on the surface. However, the velocity shows surprising fluctuations
where the cell appears to temporarily "pause" its motion on the surface (Fig. 4-6a, inset). The
magnitude of this fluctuation (Auc ~ 350 gm/s) is considerably larger than the standard deviation
of the velocity before and after this event (au ~ 40 ptm/s). These fluctuations may occur because
of local differences in surface porosity, which apply slightly stronger suction forces to the cell to
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slow down its motion. This mechanism is clearly insufficient to permanently capture cells, but it
is likely to influence the binding kinetics in a way that cannot occur on a solid surface.
These velocity fluctuations increase in frequency and duration on porous surfaces that have been
functionalized with anti-EpCAM antibodies (ou ~ 130 pm/s) (Fig. 4-6c), which are
complimentary to cancer cells of epithelial origin but not leukocytes [106]. In these
representative trajectories, cells again reach the porous surface around time t = 1 s and show a
similar decrease in axial velocity, indicating they are being advected to the surface. However,
rather than continuing at a constant diminished velocity (Fig. 4-6b), these cells continue to
decelerate and are completely arrested within a few seconds (Fig. 4-6d). The permeation flux
through a porous surface thus appears to promote the kinetics of strong, specific biomolecular
bond formation by slowing down cell rolling across the surface. As evidenced by the previous
example with non-complimentary anti-IgG, this mechanism is not strong enough to irreversibly
stabilize cell motion against the local shear field. However, in the presence of complimentary
anti-EpCAM, this enhanced cell-surface interaction allows specific cell capture to continue to
occur even at fast total flow rates. Essentially, these conditions of highly reduced shear and an
additional "braking" suction mechanism near a permeable surface lead to conditions comparable
to those at a solid surface at dramatically lower flow rates and shear.
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Fig. 4-6 Instantaneous velocity and displacement trajectories for PC3 cancer cells transported to
(A, B) non-complimentary anti-IgG, exhibiting rolling motion at constant speed and (C, D) anti-
EpCAM fluid-permeable surfaces at x = 3 cm with A = 70%, exhibiting rolling prior to complete
arrest.
4.7 Model describing arrest of specific cells based on relative velocity
In the previous section we quantitatively decribed the motion of cells on a porous surface
subjected to tangential shear as well as normal suction forces. It was also observed that compared
to a solid surface the cell surface velocity on a nano-porous permeable surface is much lower and
demonstrates a characteristic stop and go motion under tangential and normal fluidic forces. Fig.
4-7a shows multiple individual cell velocities as a function of time for the specific case of A =
70% and -r = 5 dyn/cm 2. The variation in the stoppage times, Ats for the same combination of
shear and permeation flux arose due to variation in the local porosities of the commercial
membranes. The quantification of the stoppage times of multiple cells as a function of
permeation flux is shown in Fig. 4-7b. It was seen that the stoppage time increases with
permeation flux. However since it was desirable to have intermittent stops on the
unfunctionalized surface and not a complete stop, we chose a combination of shear = 5 dyn/cm 2
and A = 70%.
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Fig. 4-7 (a) Instantaneous cell velocities on the porous surface elucidating the characteristic stop
and go motion (b) Quantification of stoppage time as a function of permeation flux at a shear of
5 dyn/cm2 (Q = 100 ptl/min) (green bar represents average stoppage time).
Since the purpose of this thesis is to isolate specific cells from a mixture through molecular
interactions between the antigens on the cells and their complimentary antibodies, we modeled
the effect of relative cell velocity and the effect of stop and go motion on these surfaces.
Therefore in this section we also theoretically understand the importance of reduced cell velocity
on porous surface. Arrest of a cell bearing complimentary antigens to the antibodies covering the
surface depends on the cell velocity, biochemical properties of the antigen/antibody pair and
their concentrations on the cell and surface respectively. The cell rolling and arrest has
previously been modeled as a two step process. [107]
[R] + [L] <- [R--L]
[R--L] < [RL]
The first step is responsible for describing the interaction of the antigens (EpCAM in our case)
on the cells to the antibody (anti-EpCAM) bearing porous surface and can be characterized by
the encounter rate (ko). The second step describes the probability of bond formation when the
complimentary antigen/antibody pair are in close proximity (P). Consequently, these two
convection of the cells across the porous surface and the rate of chemical bond formation dictate
the arrest the arrest of cells and is conveniently described using the non-dimensionalized Peclet
number. These competitive forces can be incorporated into a single parameter that defines the
probability of cell arrest (P)
P = (4-22)
1 + A,5
And 6 is the Dahmkohler number (6 = a2Kin / D; a = radius of circle of contact, Kin = intrinsic
EpCAM: anti-EpCAM reaction rate and D is the cell diffusion coefficient) and A is the
dimensionless encounter time between the cell antigen and the surface. This encounter time is
given by
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A= a2 ZD
a /D (4-23)
8a
3Ugr
As seen from Eqn. 4-23, the non-dimensionalized encounter time can be completely described by
the cell dimensions (a, D) and the relative velocity between the cell and the surface (U). As seen
from Fig. 4-8, with the increase in cell surface linear velocity, there is a decrease in probability
of bond formation. At a cell velocity of over 400 pim/s the probability of bond formation and cell
capture falls to 50%. Therefore we optimize the flow rate and permeation flux at a point where
the velocity of the rolling cells is low enough to capture. From Fig. 4-5 we see that for a input
flow rate of 6 mL/h and permeation of A=70%, the cell translational velocity is ~ 150 pim/s at at
a distance of 2.5 cm from the inlet. This cell velocity corresponds to a theoretical bond formation
and cell capture of 80% (Fig. 4-8). Additionally, we see the effect of the instantaneous stop and
go motion on probability of capture. Even if the average cell velocity is high (-2000 pm/s), the
probability of capture on the porous surface is still close tone owing to the characteristic stop and
go motion where the instantaneously the cell velocity reaches zero and the complimentary
antigen and antibodies have a large interaction time.
The modified Chang and Hammer model used above is a local model that addresses the
microscopic interaction of the antigen and antibody in an external flow field. Even though our
device introduces a transverse component of the velocity field compared to the one described
initially in the Hammer model, the model remains valid as the external forces are accounted in
the absolute cell translational velocity.
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Fig. 4-8 Plot representing probability (P) of EpCAM antigen-Anti-EpCAM antibody as a
function of cell surface velocity (black circles for solid surface and red circles on a porous
surface)
4.8 Effect of shear on cell removal
Once the capture phase is complete and the specific cells have been immobilized on the porous
surface, the bottom oulet is clamped and buffer flows through the top channel without any
permeation through the nano-porous surface (section 4.1.2). The objective of this step is to
increase the specificity of the device by dislodging the non-specific cells, while maintaining
retaining the specific target cells. To ensure the attached specific PC3 cells do not detach with
the washing buffer, it is imperative to calculate the shear experienced by the cells by the buffer.
In general, the cells remain adherent if the total shear imparted on the cells (Fs) is less than the
total adhesion force between the cell and the antibody covered porous surface (Fa), or,
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Fs < Fa
The total adhesion force on a captured PC3 cell is evaluated by using the Bell model [108, 109]
and is given by
Fa=fe Ac Cs (4-25)
Where fc is the adhesion force for a single EpCAM/anti-EpCAM bond (fc=kT/roac)~
6.6 x10-6 dynes, Ac is the contact area of the non-deformed cell with the surface
(Ac=nr 2sin(cos (r-h'+ h/r))~ 315ptm2 and Cs is the cell surface antigen density (~125pm-2
(descriptions and values of the parameters listed in Table 4-1). Consequently, the force required
to dislodge a specific cell after capture is Fa ~ 0.25 dynes. On the other hand, the cell dislodging
shear force on the cell surface during the wash step is given by
F 6ipQA (4-26)
h2W
Using the values from Table 4-1, the shear force Fs~ 1.7x10- 6 dynes. Since the force require;d to
break a single EpCAM/anti-EpCAM bond is greater than the shear force on the surface at 6 mL/h
a channel with h= 100 ptm, w- 2mm this implies that even a single bond formed between the
EpCAM antigen/anti-EpCAM is enough to overcome the shear force imparted by the fluid. In
reality hundreds of bonds are formed between the cell and the surface. Therefore once a specific
cell arrests in flow, the washing step is unlikely to remove it due to shearing at high flow rates.
We found that a flow rate of 12 mL/h provides excellent capability to remove non-specific
leukocytes, but not target cancer cells.
Parameter symbol Parameter description Value Reference
(units)
Kin Forward rate constant 105 s-1  [110]
for EpCAM/Anti-
EpCAM binding
r Cell radius 6 pim
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(4-24)
re Separation distance 0.5 nm [111]
between receptors at
min breaking force
K EpCAM/Anti-EpCAM 3.3x108 M" [111]
equilibrium constant
D PC3 diffusion constant 10-0 cm2s-1
k Boltzman constant 1.38 x 1023 m2kgs 2 K-1
a Encounter radius 5 nm [111]
h, h' Cell-surface separation 10 nm, 50 nm [108]
Table 4-1. Table listing the parameters and the associated values for calculation of probability of
cancer cell capture and shear force required to break an EpCAM/anti-EpCAM bond.
4.9 Cell Capture on Fluid-Permeable Surfaces Exceeds Solid Surfaces at
Increased Flow Rates
The capture efficiency of PC3's on both porous and solid surfaces functionalized with either
non-complementary anti-IgG or complementary anti-EpCAM are plotted as a function of total
flow rate in Fig. 4-8a. Using a mixture of PC3's and leukocytes at a ratio of 1:250, non-specific
capture of PC3's is minimal (~10%) on a solid anti-IgG surface due to the lack of
complementary bonds and decreases rapidly with increasing flow rates. For a porous anti-IgG
surface (A = 70%), the cell capture rate is slightly higher (~20%) and decreases more gradually
with increasing flow rate, reflecting non-specific adsorption due to the enhanced transport to the
surface as well as suction effects. For the solid anti-EpCAM surface, the capture efficiency
achieves a maximum value of ~60% only at low flow rates (Qin < 0.3 mL/hr). The capture
efficiency drops off rapidly with increasing flow rate, becoming negligible by Qin = 1.5 mL/hr.
In comparison, the porous anti-EpCAM surface (A = 70%) achieves the optimal capture
efficiency of 70 ± 3% up to relatively high flow rates of Qin = 6 mL/hr (Fig. 4-9a). This is
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consistent with the theoretical maximum of 70% based on the fraction of streamlines that are
expected to reach the surface. In comparison, no cells are captured on the flat surface for both
anti-EpCAM and anti-IgG and only a few cells are nonspecifically adsorbed on the anti-IgG
porous surface (Fig. 4-9c-f). As the flow rates are increased further on the anti-EpCAM porous
surface, cell capture efficiency decreases to 15% at Qi, = 30 mL/hr. Nevertheless, the maximum
effective flow rate of the porous anti-EpCAM surface is 20-fold higher than that on the solid
anti-EpCAM surface, enabling a potentially transformative enhancement in processing
throughput.
The shear-dependent capture of cells is illustrated by the concentration profile along the length of
the channel (Fig. 4-9b). A stitched image of the entire length of the device at representative flow
conditions (A = 70%, Qin = 6 mL/hr) shows that cell capture increases cumulatively with
distance, reaching -70% at x 4 cm as the shear field linearly decreases.
A c
100- 
-- anti-EpCAM Porous Surface'
--&- anti-EpCAM Solid Surface
- 0 - anti-IgG Porous Surface
80m-*--..... anti-IgG Solid Surface
m...........mI
40 -
C*.
20-
0-
2 3456781 2 34567810 2 34
Flow Rate (mL/hr)
B
EC U
4- 80 
3- - - --. 60
1 -4 ''-- 2
0
}- 0 1 2 3 4
Distance (cm)
74
Fig. 4-9 (A) Capture efficiency of PC3 cancer cells at increasing flow rates on complimentary
anti-EpCAM porous surfaces (red squares), anti-EpCAM solid surfaces (red triangles), non-
complimentary anti-IgG porous surfaces (green circles) and anti-IgG solid surfaces (green
triangles). Each marker and error bar is the average and standard deviation of 3 experiments. (B)
Capture profile varies along the channel length on an anti-EpCAM porous capture surface at
Qin=6 mL/hr and A = 70%. The transverse wall velocity vo = 141 pm/s. Representative
fluorescence micrograph of captured PC3 cells at x = 3 cm for (C) anti-EpCAM porous surface,
(D) anti-IgG porous surface, (E) anti-EpCAM solid surface and (F) anti-IgG solid surface. Scale
bar is 100 pm.
An additional insight from calculations in section 4.8 is the possibility of capture of cells with
low expression of antigens on the cell surface. Since only a few bonds between the EpCAM/anti-
EpCAM surface are required to stably arrest the cell, it is found that the capture efficiency of
lower EpCAM antigen expressing PC3-9 cells (5000/cell) was comparable (45% ± 4%) to the
higher EpCAM antigen expressing H1650 cells (500,000/cell) (58%±3%) (Fig.4-10).
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Fig. 4-10 Capture efficiency of PC3-9, PC3 and H1650 cancer cells on complimentary anti-
EpCAM porous surfaces. Each marker and error bar is the average and standard deviation of 3
experiments. The blue (DAPI) images represent nuclear staining of all the cells, red (CTO)
images represent the specific cancer cell type.
4.10 Summary
In this chapter we demonstrate the superiority of antibody functionalized porous surfaces for
capturing cells at high flow rates, compared to its solid counterparts. We demonstrate that fluid
permeable nano-porous surface enhance mass transport of cells from the channel lumen to the
reactive porous surface that bare the complimentary antibodies for specific cell capture. We
found that in a well mixed sample entering the channel, where the cells can be assumed to
uniformly distributed, the percentage cells convected to the surface is proportional to the
permeation flux through the surface. Additionally, we demonstrate that on a fluid permeable
surface, once the cells convect to the surface, the momentum transfer from the axial fluid flow
shears cells along the surface inducing cell rolling. Further, since fluid permeates through the
porous surface along the shear and hence the cell velocity decreases close to 150 Vm/s towards
the channel end. A model of probability of capture of a target cell rolling on a reactive surface
shows that probability of capture is 80% when the cell velocity is 150 pm/s and decreases
precipitously at the cell velocity increases. Finally, we demonstrate that cell capture efficiency of
of prostate cancer cells (PC3) as a function of flow rate and show that there is a 20 fold increase
in throughput over solid surfaces. Further we quantify the capture efficiency of low expressing
prostate cancer (PC3-9 cells), 45±4%, and high expressing prostate cancer (PC3) and lung cancer
(H1i650) cell lines, 60±3% and 58±3% respectively. The above-mentioned studies have resulted
in improving the capture efficiency of specific cells on antibody functionalized fluid permeable
porous surfaces at a flow rate that is 30 fold higher than the solid counterpart microfluidic device
of same dimensions (Fig. 4-10).
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Fig. 4-11 Schematic showing a 20 fold improvement in flow rate while maintaining target
cell capture efficiency (PC3) at a given concentration of background white blood cells
(500,000 cells/mL)
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Chapter 5
Partly-Porous Surfaces Enable Enhanced
Cell Capture at High Flow Rates while
Suppressing Surface Fouling
Introduction
One consideration unique to this device architecture is that cells may be advected downward so
rapidly that they overwhelm the capture surface. This would suppress the effectiveness of the
device, since layers of accumulated cells would block access to the capture surface ("caking" or
stagnant bioparticle layer formation) and ultimately impede transverse fluid flow through the
surface.
In this chapter, we consider the effect of large number of general population cells on capture
efficiency on a porous surface device and develop a device that alleviates formation of stagnant
leukocyte layer of cells at a maximal input sample concentration, in order to truly make the
device high throughput. In section 5.1, we qualitatively understand the operating conditions
under which stagnant leukocyte layer form. In section 5.2, we quantify the effect of stagnant
leukocyte layer on specific cell capture efficiency for low antigen expressing and high antigen
expressing cells. Based on previous literature, we introduce basic concepts that need
understanding during stagnant layer formation of colloids on porous surfaces and define critical
parameters that prevent formation of stagnant layers in section 5.3. Further, in section 5.4 we
experimentally understand whether the formation of these stagnant layers of leukocytes is a short
term or a long term phenomenon. During this study, we try to dig deeper to understand reasons
for stagnant layer formation on the channel edges, even in dilute suspensions and analytically
derive velocity and shear profiles for channels with low aspect ratios in section 5.5. In section
5.6 we extrapolate these derivations for a porous surface and a spatially modified microfluidic
device intended to alleviate the stagnant layer formation problem in thin channels. Finally, in
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section 5.8, we implement the concept of partly-porous surface for a multiplexed 8 channel
device with the capability of processing samples at a flow rate of 48 mL/h.
5.1 Qualitative observations on stagnant layer formation and effect on
capture efficiency of target cells
Fluid permeable porous surfaces enhance mass transport to the surface and therefore allow
interaction of specific cells with the reactive porous surface. In the previous chapter we
demonstrated a microfluidic device based on fluid-permeable, antibody-functionalized
membranes that can capture specific cells at high flow rates using two unique physical
mechanisms [112]. First, streamlines are diverted from the device outlet to the membrane,
allowing cells to be transported directly to the capture surface. Second, the diminished flow
parallel to the surface results in reduced shear, promoting increased cell-surface interactions for
selective capture of target cells and the removal of non-specific background cells. This approach
overcomes the limitations on selective capture associated with "transport" and "reaction" due to
interfacial effects and low Reynolds numbers [35, 36]. The permeation flux and hence the porous
surface wall velocity were determined using modified Darcy's law.
However, when operating at high flow rates without being transport limited, a different
complication arises - excess build-up and fouling of cells, known as concentration polarization
and "caking" [85]. We observed formation of stagnant cell layers on the porous surface at cell
concentrations above 1.5x106 /mL (or cell volume fraction of #o ~ 0.03) (Fig. 5-1) and flow rates
of 6 mL/hr and permeation flux of 70%. The combination of flow rate and permeation was
chosen based on section 4-8 where we showed the specific cell capture efficiency to be
maximum at Q=6mL/hr and A=70%. Keeping the shear due to fluid flow and permeation
constant, we observed that the stagnant layer formation is a function of inlet sample cell
concentration. In order to demonstrate this we used leukocytes ("buffy coat") isolated from
whole blood using deterministic lateral displacement [101] and resuspended to different
concentrations to understand the effect of concentration on caking. These cells were
fluorescently labeled (CellTracker calcein green, Invitrogen, Carlsbad, CA) following the
manufacturer protocol. For each condition the entire channel was imaged using a 4X objective
and a 10 X objective. For solid surfaces no buildup of leukocytes was found on the surface.
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However, for porous surface, 15% of the total channel area was covered with leukocyted at inlet
cell volume fraction at #e~0.01 (500,00 cells/mL) and 90% was covered at 0-0.03 (1.5x106
cells/mL) (Fig. 5-1)
Solid Porous
(oc 0.01 __m1c
(O~ 0.03
Fig. 5-1 (Left) No deposition of leukocytes from buffy coat on solid surface (Right) enhanced
mass transport of the porous surface at A=70% causes ~ 15% area coverage due to stagnant layer
formation at o-0.01 (0.5x106 cells/mL) and ~90% area coverage at -.~0.03 (1.5x106 cells/mL).
5.2 Effect of stagnant layers on specific cell capture
In this section we explore the effects of stagnant layer formation on specific cell capture.
Previously, in literature formation of stagnant cell layer of the general background cell
population has been associated with the waning performance of porous surfaces during filtration
[113]. Formation of stagnant layer on porous surfaces poses two problems. Firstly, formation of
a stagnant layer physically cuts off access to the anti-EpCAM antibodies immobilized on the
porous surface. As a result, the EpCAM antigens on the cells cannot interact with the anti-
EpCAM on the surface and therefore cannot be arrested. Secondly, formation of stagnant 'cake'
layer reduce permeation flux responsible for enhanced mass transport at high flow rates if the
resistance offered by the stagnant layer is comparable to other elements of the device. The
decreased permeable flux is due to addition of a resistive component to the bottom arm of the
lumped resistive model (Re). The resistance offered by this cake layer can be described using the
Carman-Kozeny equation.
(180(11
c d 2 E 3
P (5-1)
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Where, & ~ porosity of the cake layer and the value lies between 0 and 1, 6, is the cake thickness,
dp is the cell diameter. Assuming cells are sphereical, a monolayer (& ~0.6) of 10 pm cells has R,
12
-10
However, in our device we see that the nano-porous surface with a pore diameter of 200 nm and
porosity of 10% has resistance on the same order as resistance due to a monolayer of cells (Table
3-1). In this scenario the cake layer resistance and the membrane resistance is overwhelmed by
the addition of the external resistances to the top and bottom outlets (~ 1013) which continue to
allow permeation flux through the nano-porous surface and deposition of multiple background
cell layers. In order to understand effect of stagnant cell layers on specific cell capture on the
anti-EpCAM coated porous surface, we pre-conditioned the device by forming stagnant layers of
leukocytes on the surface. These stagnant cell 'cake' layers were quantified by scanning the
entire channel using a 4x objective and was normalized against the total channel area (Section
5.4.1). Prostate cancer cell line PC3 were spiked into the buffer solution at 1000 cells/mL and 1
mL solution was processed through the chip at 6 mL/hr, A=70% permeation. During these
experiments, we measured the permeation fluxes through the porous surface for the duration of
the experiment for each condition and found that it remained unchanged and consistent at 70%.
Additionally, we observed that the capture efficiency of larger number of EpCAM antigen
expression of PC3 cells (50,000 /cell) remained constant at ~ 70% until the cake area coverage
was ~ 60%. However, the capture efficiency reduced significantly (- 50%) past cake area
coverage of 78%. For the lower antigen expressing PC3-9 cells (5000/cell) the effect of cake area
coverage was more significant. The capture efficiency decreased from 50% ± 4% at stagnant
bioparticle coverage of 18%±3% to capture efficiency of 25 % ± 4% at a stagnant bioparticle
coverage of 58% ± 4% (Fig 5-2). Based on these results, we believe that porous surface coverage
with background leukocytes in the sample screen the target cells from interacting with the
specific antibodies. In the following sections we dive deeper into the theory of stagnant layer
formation to understand the forces and mechanisms that are responsible for caking and alleviate
the phenomenon, restoring the optimal operation of porous surface microfluidic devices in
concentrated samples.
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Fig. 5-2 Capture efficiency of specific prostate cancer cells (PC3) as a function of cake area
coverage.
5.3 Theoretical background on stagnant layer formation
Buildup of stagnant layer of large particles such as cells, much larger in size than the nanopores
on the surface, is a result of very high convective drag that enhances mass transport of cells to
the nanoporous surface relative to the shear forces that translate the cells and the suggested back
transport mechanisms (lift forces, stokes-enstein diffusion diffusion) in the system [113]. Since,
our system operates in laminar regime (Re<<1), inertial forces are negligible. Additionally, for a
10 im cell diameter the Stokes-Einstein is 2x 0-7 cm 2/sec, which is small compared to the
permeation flux through the nanoporous surface. Therefore the formation of the stagnant layer is
due to excessive permeation flux relative to the shear forces translating the cells. During stagnant
layer formation, five stages have been clearly demarcated in the literature in the past [8]. These
are described as (1) Fast initial sorption of macromolecules (2) Buildup of the first mono-layer
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(3) Buildup of multi-layers (4) Densification of multi-layers. Stage 3 and 4 are associated with
decreased permeation flux through the porous surface. In this thesis, we will only focus on
conditions up until formation of the monolayer, as it is the onset of the monolayer formation that
is detrimental to specific cell capture (see section 5.2).
Stage 1- Initial deposit
0 0
* .
Stage 3 - Sublayer rearrangement
Stage 2 - Aggregate formation
0
* 0S.@
0 S
Stage 4 - Multiple layer formation
Fig. 5-3 Periods of different physical phenomena during cake formation and flux decline [8]
5.3.1 Theoretical considerations and stagnant layer onset modeling
In order to understand the qualitative observations in section 5.1 and 5.2, we explore the forces
underlying the stagnant layer formation. The theoretical analysis consists mainly of two parts,
the fluid and particle trajectory calculations (see section 4.2) and the stagnant layer deposition
and permeation flux calculations. The governing equations for the fluid and particle trajectories
make use of Navier-Stokes equations and modification of Newton's second law (Faxen's law).
To calculate the onset of cake growth we use the critical flux and critical distance calculations.
Together, these subdomain models allow prediction of stagnant layer formation in terms of
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global parameters such as sample concentration, particle radius, channel shear and permeation
flux. In order to simplify the model, the following assumptions are considered.
1) Sample is a dilute suspension of cells; The particles do not influence the fluid field nor do
they interact with each other
2) Cells are rigid and non-deformable and Brownian motion and inertial effects are
negligible
3) Pressure difference and the wall flux is constant
4) Material properties of the fluid and membrane remain constant and the sample is well
mixed, implying that the entering particles are uniformly distributed at entrance.
The physical situation under consideration is described in Fig. 5-4. The sample suspension is
composed of a Newtonian fluid and neutrally non-bouyant cells in the bulk are convected from
the dilute suspension to the porous surface. In the bulk the cells do not interact with each other
and the cells follow the fluid streamlines. The particle suspension far away from the wall is
constant and given by *. Close to the porous surface a concentrated layer of cells translates and
acts as a non-Newtonian fluid and the flow of solution above this layer imparts a tangential shear
stress r(x) which we assume to decrease linearly along the channel length because of constant
permeation flux. This shear stress is position and viscosity dependent and is given by
6p__(p)Q__ Q_ xT(X) = 0q(qo)Qo, (1 . )h2W Q0n L (5-2)
The effective viscosity of the concentrated cell layer has been experimentally found and
described in terms of the local concentration [114]. As can be seen from Eqn. 5-3, the effective
viscosity in the concentrated cell layer increases with the cell volume fraction
7(#)~{I+1.5 /WeOw }2
(1 0.58 (5-3)
Where , is the cell volume fraction in the stagnant bioparticle layer. Previously, Romero and
Davis modeled a similar system where the permeation flux through the porous surfaces was
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small. However, even in this system they found that the formation of stagnant layers occurs
when the cell packing fraction at the wall reaches a certain maximum ($max). Therefore, the onset
of stagnant bioparticle layer is a function of three key variables: Shear stress, permeation flux
and cell volume fraction in the concentrated layer.
Cell radius (a) Bulk
layer
Concentration
.. y layer(e,)
Input sample
concentration
((0)
Fig. 5-4 Schematic showing the important parameters under consideration for onset of stagnant
layer and the difference in the cell volume fractions in the bulk and concentration layers.
However, avoiding stagnant layer formation scenario requires that the flux of cells being
advected to the surface must not exceed the flux of cells translating across the surface, or at
steady state
Mi- MO = fu($)dy - fV,,dx > 0
0 0 (5-4)
This condition can be achieved at a given bulk cell concentration ($o) by making the permeation
flux as large as possible while retaining sufficient axial flow enough to drive cell rolling due to
shear stress. Romero and Davis have considered the scenario of hard spheres accumulating at a
porous surface and have derived an expression for a critical distance xer where particles become
close-packed in a "cake" layer [115]:
xR= 4 (X) (55)9r('0 U, (o0 55
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where a is the particle radius, T(x) is the surface shear stress, go is the initial bulk volume
fraction and po is the solution viscosity.
Cell radius (Re)
Bulk cell volume
fraction (D,)
Shear stress T(x)
Permeation flux, V,(x)
Critical Distance (xy)
Fig. 5-5 Schematic depicting the critical distance for the onset of stagnant layer cake formation
and the important parameters associated.
The critical permeation flux Qc, is primary a function of the bulk cell concentration and is given
by:
A p = D(p')dp' ((p - po)D(p) 5-6)
where <Pmax is the maximum packing density on the surface, assumed to be ~ 0.6 for hard spheres
and i1(<) is the effective viscosity as described in Eqn. 5-3. This is a conservative estimate which
may underestimate the packing density of deformable cells [115]. Nevertheless, the empty space
between cells in a close packed layer (-40%) is still considerably larger than the membrane
porosity (~10%), making it unlikely that a single close-packed layer of cells would block a
significant number of pores or lead to a large cake resistance (Rc- 1012) thereby maintaining
constant permeation flux. This calculation thus assumes that the presence of ~10 pm cells does
not affect the fluidic resistance of the membrane or associated transverse flux. The permeation
flux and thickness of stagnant particle layer formation in the critical and the pre-critical region
are defined as:
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Pre-critical region (x < xcr): V (x) = V,o - ,8,, = 0
Am (5-7)
Post-critical region (x > xr): V.(x) = Vo = ; = 2H,[1- Xcr /)6]
A,, x (5-8)
Where, 6st is the thickness of the stagnant layer formed along the porous channel. Onset of caking
along with the thickness of the stagnant layer achieved as a function of distance from the
entrance of the channel is shown in Fig. 5-6.
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Fig. 5-6 (a) Distance from the device entrance where the caking onset takes place and the
thickness of the cake reached at each location as a function of feed concentration 4o (0.05, 0.03
and 0.01) (b) and, permeation flux v. (A=70%, 80% and 90%).
Phase diagrams for the critical distance xer as a function of axial distance x and initial cell volume
fraction <po at varying permeation fluxes are shown in Fig. 5-6. To prevent caking,the critical
distance xer should exceed the device length L at any point along the length of the channel so that
the particle fraction on the porous surface never reaches its maximum cell packing density, <pmax.
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In general, the critical distance xcr decreases with increasing initial cell volume fraction go, since
a smaller enhancement in concentration is required to reach the maximum. In the case of
minimal permeation flux (A = 10%), slow advection to the surface means that caking will only
occur at relatively high bulk volume fractions. For instance, for go = 0.04 - 2 -106 cells/mL, ePmax
is reached at xer = 3 cm. Experimentally, operating in this regime leads to a visible buildup of
white blood cells on the reaction surface, despite the lack of specific cell-surface interactions. A
further increase to go = 0.05 - 2.5 .106 cells/mL, corresponds to xcr essentially at the entrance,
which is not a usable condition. In general, operating at this minimal flux regime (A = 10%) is
both inefficient and unselective, since 90% of the cells never reach the surface, but those that do
are not subjected to sufficient shear to remove white blood cells while retaining cancer cells.
At the higher permeation flux described previously (A = 70%) and go = 0.1; xer = 0.8 cm,
corresponding to caking within the device (Fig. 5-7). Instead, at go = 0.1, corresponding to ~
500,000 cells/mL, the critical length xer = 5 cm is larger than the length of the channel (L = 4 cm)
and caking should not occur within the device. Experimentally, device operation was optimal
under these conditions, achieving efficient cell transport, selective capture and minimal
accumulation of white blood cells at relatively high flow rates.
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Fig. 5-7 High permeation flux (A = 70%) condition. At a critical value of initial volume fraction,
the maximum close packing is reached along the length of the channel, causing excess cell
buildup ("caking") and hindering cell capture (white dotted line). Devices were operated in the
optimum regime (po = 0.1, Qin = 6 mL/hr, A = 70%) to maximize throughput without excess cell
buildup (red line).
5.4 Temporal formation characteristics of stagnant bioparticle layers
In the previous section we investigated important parameters that dictate steady state onset of
stagnant layer formation on the porous surface. The question remains as to how long it takes to
reach this steady state? Does it deposit very quickly, on the order of seconds or minutes or is a
much longer term phenomenon. An understanding of the temporal stagnant layer growth would
allow us to define the operating conditions for the porous surface device. In order to understand
the timescale at which this cake layer forms, we used fluorescently labeled white blood cells to
track fraction of channel area covered by cake as a function of time.
5.4.1 Image analysis of stagnant layers
Caking kinetics were analyzed using built-in functions in MATLAB. Grayscale images of
accumulating fluorescent cells were thresholded to binary black and white images using Otsu's
method. This threshold value was recomputed for every image to compensate for photo-
bleaching and manually verified. The total area coverage of fluorescent cells was measured using
a pattern-weighted formula that accounts for distortions due to pixel biasing. Spatially localized
caking phenomena were assessed by integrating pixel intensities for selected regions of interest
of varying width and distance from the centerline.
5.4.2 Temporal growth of stagnant layers
In section 4.8 we found that a permeation flux of 70% through the porous surface allowed a 20
fold increased throughput (6mL/hr) while maintaining the capture efficiency (-73%) over its
solid counterpart in PC3 cells. Keeping the input feed cell fraction constant, the rate of stagnant
bio-particle layer formation increased with increasing percentage permeation flux. At A=50%,
the time taken to form a monolayer of leukocytes - 400s at # - 0.05. However, at 00 ~ 0.03 and
00 ~ 0.01, the fractional area covered saturates before reaching ~ 0.6 (Fig. 5-8). At these low cell
volume fractions even though considerable area remains "un-caked", the throughput remains
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limited because of lower number of cells/mL. However, at A=70% we see substantial fractional
area of the channel covered for *o ~ 0.05, 0.03 and 0.01. At *0 ~ 0.05, fractional area coverage
reaches 0.6 around 220 s, whereas *0 ~ 0.03 saturates at 0.6 at 1050 s. A lower cell volume
fraction of 0 ~ 0.03 saturates at 0.5 - 1200 s. It is however, interesting to note that even for low
permeation conditions and cell fraction volumes in the bulk, there is stagnant bioparticle layer
buildup on along the channel edges. Analysis of this phenomenon will be studied in the next
section. It is also to be emphasized that the rate of particle deposition is nearly constant up until
the steady state is reached for each combination of input cell feed fraction, shear rate and
permeation flux. This phenomenon can be explained because the permeation flux through the
surface is dependent and limited by the resistance of the membrane (1012) and output bottom
resistance (1013) compared to the low resistance offered by the monolayer of cells (1012) on the
surface according to Carman-Kozeny equation. Therefore theoretical predictions for the stagnant
bioparticle layer formation in our system follow the standard filtration theory for dead end
filtration systems for operating regimes where stagnant bioparticle layer forms [116].
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Fig. 5-8 (a) Channel area fraction growth rate for A=50% at *o = 0.05, 0.03 and 0.01 (b) for A
50% at #e = 0.05, 0.03 and 0.01. Scale bar = 500 pm
Color coded kymographs represent the deposition of fluorescently labeled leukocytes across the
width of the channel on the porous surface over the span of ~ 1200 s. We see that for a
permeation flux of 70% the stagnant bioparticle layer formation occurs at higher feed fractions
(o-0.03) and the onset happens around ~ 200 s for the top edge and 240 s for the bottom edge
(Fig. 5-9).This is represented by the red color on the kymograph which indicated formation of at
least a single monolayer of leukocytes on the surface. The asymmetry in cake onset could be due
to local porosity and particle distribution across the channel. With time, as more leukocytes get
to the surface, the small immobilized layer of cells acts as a catalyst for the stagnant layer to
grow inwards towards the center. It was experimentally observed that once a critical size of
stagnant layer (> 500 pm 2) is reached, it becomes a local barrier for the cells that travel with
linear surface trajectory directly behind it thereby allowing growth of stagnant layer over time.
Similar conditions are seen for A=50%, however, for this condition the stagnant layer formation
begins at a higher concentration of 0*-O0.05 or 2.5x 106 cells/ mL.
In the pictures shown in Fig. 5-8 it is interesting to note that even for low permeation conditions
and cell fraction volumes in the bulk (#~0.0 1), formation of stagnant bioparticle layer buildup
along the channel edges and small islands in the center were observed. Formation of small
islands for different permeation conditions and at low cell volume fractions can be described by
the local variation in the porosity of the surface which leads to a imbalance of permeation
relative to the local shear field. Upon measurement of these small islands, the size of most these
islands was less than 1 00pm2 at the end of the experiment.
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Fig. 5-9 Kymographs of cake growth for different sample feed fractions ( = 0. 01, 0 .03 and
0.05) and permeation fluxes (A=50% and 70%).
Further, analysis of the growth rate of stagnant layer formnation at the edges ( 300 ptm from the
wall) and center of the channel showed that the stagnant layer grows faster along the edges (~10
fold in the transparent blue region) in comparison to the center of the channel (Fig. 5-10) till both
reach saturation. The transparent red section in the figure demarcates the amount of time it takes
for the porous surface to form a monolayer (fractional coverage ~ 0.6). We see that although the
edges reach the monolayer stage at ~170 s, the middle part never reaches the monolayer stage.
Theoretical understanding of why this occurs will be studied in the next section.
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Fig. 5-10 Fractional area coverage as a function of time for the
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5.5 Edge effects in microfluidic channels
The stagnant leukocyte layer growth experiments showed that the onset of cake first happens
within 300 ptm from the channel edge (Fig. 5-9). We believe that this phenomenon is a result of
the wall edge effects of the microfluidic channel which reduces the tangential shear that
translates the cells along the porous surface. The resulting imbalance between the shear and
permeation flux results in initiation and continuation of stagnant layer growth.
Usually, analysis of microfluidic devices neglects the role of the side walls of the channel due to
the assumption that the width of the channel is large compared to its height. In our device, the
width to height ratio (w/h) is ~ 20. To evaluate the edge effects we begin with the navier stokes
equation, derive an analytical expression for vx(y,z) and finally use the velocity field in the x
direction to find the shear stress in the channel with the presence of walls.
Navier stokes equation in the vector form can be written as
av
p-pv.Vv = -Vp+ pV 2v + pgat (5-9)
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Eqn. 5-9 simplifies based on the assumptions (1) steady state and fully developed flow (2) no
velocity components in y- and z- direction with pressure variation along x, resulting in
0 = -Vp + pV2V (5-10)
With boundary conditions that velocity on each surface is o
BC's :y= ±h/2,v,(±h/2,z)= 0
z = ±w /2 v, (y,0)= v,(y, w)= 0 (5-11)
Additionally, since in this case we are not going to use the general assumption that w>>h, we
also cannot assume that Eqn. 5-10 is homogeneous. The velocity component vx, can therefore be
written as a sum of two terms, one that depends on y coordinate only and the second term that
depends on y- and z- coordinates:
vx(y,z) = vx(y) + < (y,z) (5-12)
where,
Aph 2 (14y 2
8pL h2 (5-13)
Substituting Eqn. 5-12 in 5-13 we get two equations
0 Ap d 2v,
L dy 2
0= +
ay 2  8z 2  (5-14)
In addition to satisfying BC's 5-11, Eqn. 5-12 should also satisfy
BC's:y= ±h/2,v, =0,# =0
z= ±w/2,# =-v
z=0, =o0
Bz (5-15)
Using these boundary conditions, the solution for the velocity field is
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(2n + 1)n\2 1n
Aph 2  4y2 Aph 2  32(-1) cosh( h + ) Cos( (2n h 1)n
v , y" Z)edge effec , = ( 1 2 p - h + 1 h84L h2  84[(2n + 1);r]' cosh( (2 +I))
2h (5-16)
Under the assumption that close to surface (height 5 pm over the porous surface (center of the
cell)) the shear variation is linear we use Eqn. 5-17 to get obtain an expression for shear stress,
v,(y,z)
Y (5-17)
Eqn. 5-17, describes the reduced shear stress dependence in the Y and Z directions due to edge
effects in a microfluidic channel with an aspect ratio of w/h. The resulting normalized shear
variations across the channel width for a micro-fluidic channel with aspect ratio of w/h- 50 and
w/h ~ 20 are shown in Fig. 5-11 a and fig. 5-11 b respectively. For an aspect ratio of 50, the
variation in shear stress due to the wall is - 2%. However, when the aspect ratio drops down to
20, a decrease of 30% compared to the channel center occurs within 300 im of the channel edge.
Since our channel has a aspect ratio of 20, this implies shear decrease not only along the channel
length due to decrease in shear as a result of permeation flux, but also a decrease in shear across
the channel width due to the channel edge effect.
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Fig. 5-11 (a) Percentage difference between the shear stress in an infinitely wide channel on a
solid surface and on a (b) porous surface
5.6 Spatially modulated micro-flows for enhanced cell capture
A number of hydrodynamic mechanisms have been explored to suppress cake formation at high
concentrations and throughput, including surface roughness, inertial lift, pulsatile (unsteady)
flows, and Dean flows [87]. Unfortunately, these schemes cannot be easily applied to selective
separation, since the enhanced local shear could also remove captured target cells. In order to
remove the stagnant bio-particle growth at the edges of the channel, we therefore fabricate a
spatially modulated microfluidic porous surface device where the surface of the device close to
the edges was made solid. The fabrication and integration process for these PDMS channels was
similar to the process described in section 3.1 with the top channel dimensions L=4 cm, w=2
mm, and h=100 pm and bottom channel dimensions L=4 cm, w-- 1.6 mm, and h=100 prm.
5.6.1 Shear variation on a porous and spatially modulated porous surface
As discussed in the previous section, there is a considerable decrease in translational shear close
to the channel edges (~30%) even on solid surfaces. This phenomenon is further enhanced on a
porous surface where in addition to shear variation across the channel width, the translational
shear also decreases along the length. At the channel outlet (x=L) the shear stress at the edges is
therefore only 20% of its value at the center for a representative case of A=70% (Fig. 5-12).
Therefore if we are operating under the optimized conditions shown previously in Fig. 4-8, the
shear along the edge of the channel at the outlet would be 0.3 dyn/cm 2 (20% or 1.5 dyn/cm2 at
x=L in Fig. 5-12). A combination of low translational shear (0.3 dyn/cm 2 ) and high permeation
(A=70%) gives a zero critical distance at the channel end based on Eqn. 5-5 indicating that
stagnant layer formation should occur even at o-0.01. In order to limit the wall effect we
therefore used a partly porous surface. Solid surface at the edges (x=2H ~ 200 pm in our case)
pacify the wall effect and pushes the shear back up to the same level as it would be for a solid
surface case i.e. 76% of the shear down the center of the channel (Fig. 5-12). Since for x>2H the
wall effect is negligible, the center of the channel still benefits from the optimized reduced shear
and increased cell-surface interaction on the porous surface.
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Fig. 5-12 (a) shear variation across the channel width on a porous surface (b) on a spatially
modulated porous surface, and the corresponding stagnant leukocyte layer (green)
5.6.2 Effect of partly porous surface on stagnant layer formation
In order test and quantify the effect of stagnant layer formation on the surface of the modulated
porous surface device we used fluorescently labeled leukocytes and measured the effect of
increasing particle fraction on stagnant layer formation over time. The other operating conditions
for the experiments included an input flow rate (Qin) - 6 mL/h and permeation flux - 70%. The
fractional area covered was calculated based on the image processing algorithm described in
section 5.4.1. It was found that the stagnant layer reduced to less than 10% for the spatially
modulated channels as opposed to the completely porous surface counterpart at *o=0.05 and
0.03 (equivalent of 2.5x1 06 cells/mL and 1.5x1 06 cells/mL). Various widths of solid surface were
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tried at the edges, however, the smallest width at with the fractional stagnant layer coverage was
found to be ~ 200 tm. Increasing the solid surface width further led to an increase in the number
of cells traversing this region without capture, leading to a reduction in the overall capture
efficiency.
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Fig. 5-13 (a) Growth kinetics of the stagnant leukocyte layer on the porous surface on porous
and spatially modulated nanoporous surfaces (b) Kymographs for the growth curves, show the
onset of set across the width of the channel for the two kinds of surfaces at Oo=0.05 and 0.03 and
permeation of A=70%.
5.6.3 Specific cell capture efficiency on a spatially modulated porous device
PC3 cells labeled with Cell tracker Orange dye were spiked into buffy coat obtained from human
blood through deterministic lateral displacement. The channel surface was functionalized with
anti-EpCAM antibody using the protocol mentioned in section 3-1. The PC3 spiked sample was
flown into the spatially modulated device at 6 mL/hr for 1 hr at A=70% and 0-0.03 and 0.05.
The cells were then subsequently fixed and counted using an automated image processing
algorithm developed in NIS elements. Capture efficiency of PC3 cells achieved on
complimentary anti-EpCAM at *o=0.03 is 68% ± 6% and 54% ± 5%at 0e= 0.05. The capture
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efficiency on the indented channels was ~ 10 fold higher than its porous counterpart at *o=0.03
and 9 fold higher at *o=0.05 (Fig. 5-14). These experiments were repeated 3 times for each
condition for mean and standard deviation calculation.
Porous Channel Spatially modulated nano-
porous channel
A=70pm
615opim
WBC
PC3
O=0.03 =0.05 =0.03 0&0.05
08
0.6
0
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0.2
0 0 -- -- ----- ---- 
Solid Nano-porous Spatially modulated
nano-porous
Fig. 5-14 (a) Images of the leukocyte stagnant layer (green) and the target PC3 cell capture (red)
on a porous surface (b) on partly porous surface (c) Capture efficiency comparison on solid,
porous and partly porous surface for 0- 0.01 and #- 0.03. Scale bar = 500 pm
5.7 High throughput cell capture
Use of partly porous channels reduces the stagnant bio-particle formation on the porous surface
and allows for increased input cell feed fraction to be used in the device (#0~0.05, 5 fold) over its
completely porous counterpart (#-O.01). This allows for sample processing to be closer to
concentrations of "buffy coat" (2.5x106 cells/mL) obtained from deterministic lateral
displacement method derived from human blood. Given the physical scalability of the current
device, we fabricated a 8 parallel channel spatially modulated device using methods described in
section 3.1 (Fig. 3-1). The device demonstrated linearly scalability in the sample throughput
processed through the device and was capable of processing samples at 48 mL/h, 8 times the
flow rate of the single channel mentioned in section 4.8. Therefore, the spatially modulated
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porous surface immuno-chromatography device offers considerable advantage (~ 10 fold) over
the other solid surface immuno-chromatography devices of similar footprint area. Additionally,
even at these high sample processing speeds, the device maintains an impressive capture
efficiency for low and high expressing cancer cell lines (PC3-9 and H1650 respectively) spiked
into buffy coat mixtures. We observe a capture efficiency of ~54% + 3%, 60% +4% and 67%
2% for 5, 50 and 500 PC3-9 prostate cancer cells (- 5000 antigens/cell) spiked into 2.5x106
WBC's/mL. Similarly, capture efficiency for PC3 prostate cancer cells is 65% ± 6%, 70% + 4%
and 69% ± 5% is seen for 5, 50 and 500 PC3 cancer cells (- 50,000 antigens/cell) spiked into
2.5x10 6 WBC's/mL and 69% + 3%, 70% ± 3% and 69% + 5% is seen for 5, 50 and 500 H1650
non small lung cancer cells (- 250,000 antigens/cell). These results indicate that the device is
effective for capturing cells with low antigen expression as well as high antigen expression.
Further, large throughput allows processing substantial volumes (48mL) in 1 h thereby making it
possible for small number of target cells to be spiked/mL of the sample. Together, these two
attributes open up avenues in the future for isolating rare cells from complex samples.
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Fig. 5-15 Heat map showing the capture efficiency of PC3 cells in spatially patterned partly
porous surface device for different target cell to background cell concentration and cell lines.
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5.8 Summary
In this chapter we understood the effect of stagnant leukocyte layer on capture efficiency and
critical parameters responsible for its formation. We observe that under optimal specific cell
capture parameters (shear ~ 5 dyn/cm 2, A=70%) discussed in chapter 4, the stagnant layer forms
above a cell volume fraction of * ~ 0.03 and results in a precipitous drop (~ 68% to -20%) in
capture efficiency once the fractional channel area covered reaches ~ 65%. Additionally we
understand that this stagnant layer formation happens over the course of minutes (~ 5 min).
Under these circumstances, the device function would be suboptimal as it would stop capturing
specific cells. We explored leukocyte layer growth at the edges and middle and found that
accelerated stagnant layer growth in our system and found that the onset and growth at the edges
is much faster than in the center (10 fold). Once formed at the edges, the stagnant layer
infiltrates inwards and covers the entire channel. We understood the issue of onset of stagnant
layer at the edges and found that for low aspect ratio channels the shear at the edges (within ~
300 ptm) decreases by 80%, which creates an imbalance between the translation shear and
normal suction force. Insights from the theoretical model were used to design a spatially
modulated porous surface device, where the surface close to the walls (-250 pm) was made solid
and the rest was porous. This device maintained a substantially high shear (>1.5 dyn/cm2) at the
edges to prevent stagnant layers, while the central channel benefitted from the increased
interactions and optimal shear described in chapter 4. Finally, we implemented the concept of
partly porous surface for a multiplexed 8 channel device with the capability of processing
samples at a flow rate of 48 mL/h.
The ability to multiplex channels allows us to linearly increase the input sample flow rate in
proportion with the number of parallel channels. The partly porous microfluidic design approach
described in section 5.7 further elucidates the devices capability to process samples at high
concentrations without stagnant layer cake formation (Fig. 5-16). A combination of increase in
flow rate and increase in initial concentration leads to a total increase in throughput ( 150 fold)
for capturing specific cells from complex mixtures that are otherwise similar in physical
characteristics to the target cells of interest.
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Fig. 5-16 Schematic summary of increase in concentration (-5 fold) of the input sample using a
partly porous surface compared to a porous surface while maintaining a capture efficiency of
theoretical maximum (-70%).
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Chapter 6
Conclusions and Future Work
6.1 Conclusions
A fluid-permeable capture surface has been demonstrated that overcomes both of these
limitations, enabling excellent capture efficiency and selectivity at flow rates 20-fold higher than
a comparable device with a solid surface. Remarkably, by controlling the fluid permeation
through the membrane, streamlines can be diverted into the membrane even at high flow rates.
On a cellular scale, the transverse flux has an additional advantage in that the transverse flow
through the membrane significantly decreases the axial fluid flow near the surface. Thus, despite
high overall flow rates, cells near the surface experience a considerably diminished shear as well
as a "braking" suction force. In contrast, these reduced surface shear conditions can only be
achieved near a solid surface at substantially lower flow rates. These transport and cell-surface
mechanisms can be independently varied by adjusting the overall flow rate or ratio of transverse
to axial flux, respectively, allowing for device operation to be optimized.
In order to reproducibly perform the experiments we developed the lumped resistor model that
helped predict the fluid flux through the top and bottom channels of the device by taking into
account all the dependent geometrical parameters of the elements in the system (channels and
membranes). The use of high resistances at the top and bottom outlets of the device, helped
"short out" the variations in the porosity of the membrane, thereby allowing the fluid flux split
and the flow rates to be controlled precisely. Further, the use of resistances allowed a constant
pressure drop across the membrane which resulted in constant permeation flux through the
membrane. Compares to similar systems without these high external resistances, our device was
able to bias streamlines and reduce shear along the entire length of the channel.
Conventional platforms based on adhesion-based cell capture on solid surfaces exhibit highly
diminished capture efficiency at elevated flow rates due to two coupled mechanisms. The rapid
advection of cells through the device limits the transport of cells to the capture surface. As a
result, only a small fraction of the total cells in a sample actually reach the surface.
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Second, cells near the surface experience strong shear stresses that cause rapid rolling and
translation across the surface. The limited interaction between cellular receptors and surface
ligands hinders the formation of strong adhesive bonds; any transient bonds that do form are
more likely to dissociate at elevated forces. Although the first limitation has been addressed by
increasing the capture surface area or enhancing mixing, the second limitation is more difficult to
overcome, since the shear stress scales directly with the flow rate near a solid surface. Given this
limiting flow rate, the overall throughput can still be increased by scaling up to multiple parallel
channels, but this approach soon becomes impractical for device manufacture and readout.
Theoretical and experimental analysis of increased mass transport to the porous surface revealed
that there exists a critical state of device operating parameters (Shear stress, input cell volume
fraction and permeation flux) beyond which the device starts acting like a mechanical filter.
Under these conditions a stagnant layer of leukocytes in the cancer cell spiked sample forms on
the cell surface which precludes the target specific cells from interacting with the reactive porous
surface. Our analysis showed that once the fractional area covered by the leukocytes reached ~
60%, there was a precipitous drop in the capture efficiency of the device. It is therefore
imperative to understand the mechanics of the stagnant layer formation in order to assuage its
formation. We use the critical distance parameter (xcr) to help us estimate the location at which
the stagnant layer onset begins and determine the operating conditions such that at steady state
the critical distance is greater than the length of the channel. Based on our channel dimensions
and previously determined optimal conditions for specific cell capture (shear 5000 s5 A=70%),
we were able to successfully process a sample with 0.5x10 6 cells/ mL without any bio-particle
layer formation. However, as the cell concentration is increased to 1.5x106 cells/ mL we see a
layer of leukocytes form. A deeper dive into understanding the kinetics of stagnant layer growth
revealed that this stagnant layer formation begins at the edges of the channel and grows inwards.
The onset of the cake layer at the edges can be attributed to the substantial shear variation across
the width of the microfluidic channels with low aspect ratio (w/h < 20). Analysis of the velocity
and shear variation showed that on a porous surface the edge effect becomes more pronounced s
decreasing the shear at the edges by upto 80% within x < 2H. A temporal analysis of the cake
layer onset confirms that the onset happens within 250 tm of the channel edge. We therefore
establish a complete understanding of the operating conditions under which the porous surface in
microfluidic channels would not experience stagnant layer formation.
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Based on our understanding of the temporal and steady state formation of stagnant layers and
target cell capture, we designed a spatially modulated porous surface that alleviated the decrease
in the shear stress at the edges. Solid surface at the edges (x=2H ~ 200 pm in our case) pacify the
wall effect and pushes the shear back up to the same level as it would be for a solid surface case
i.e. 76% of the shear down the center of the channel Since for x > 2H the wall effect is
negligible, the center of the channel still benefits from the optimized reduced shear and increased
cell-surface interaction on the porous surface. The capture efficiency on the indented channels
was - 10 fold higher than its porous counterpart at *o=0.03 and 9 fold higher at 0=0.05. Since
the goal of this thesis was to improve throughput of sample processing, we improved the
throughput of the device ~ 50 fold over its porous counterpart. Finally, we extended the use of
spatially modulated porous surfaces to a microfluidic device with 8 channels in parallel with a
throughput capability which scaled linearly. As such we were able to achieve sample processing
flow rates of 48 mL/h which allowed us to isolate cancer lines (low and high EpCAM antigen
expressing) as low as 5 cells/mL spiked into buffy coat in 1 hr.
6.2 Outlook
Work in this thesis has opened up several new avenues for investigations
As seen in chapter 4, fluid-permeable surfaces is that the shear stress decreases linearly along the
length of the channel, reminiscent of microfluidic devices that use a Hele-Shaw channel
geometry (with solid surfaces) [117]. As a result, the density of captured cells increases with
distance in the channel, since cells are more likely to remain arrested at lower shear. This trend is
the opposite of what is often observed on solid surfaces, where the shear is constant and the
density of captured cells decreases exponentially along the length of the device [22]. In both
cases, the spatial distribution of captured cells reflects how the target subpopulation interacts
specifically with an antibody-functionalized surface at a particular shear rate. An intriguing
possibility is that additional biophysical information may be encoded in this distribution, such as
the variation in receptor expression levels. For instance, circulating tumor cells in a clinical
sample may exhibit much greater heterogeneity than a spiked cell line [106], leading to a
different distribution of captured cells in the channel. These effects could be explored using
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improved surface chemistries [118] as well as spatial patterning schemes such as stripes [119],
gradients [120], or discrete regions of different capture antibodies [121].
In addition to selective cell capture, microfluidic platforms incorporating porous surfaces may be
useful as a well-controlled in vitro assay to elucidate cell trafficking behaviors in vivo. Indeed, a
variety of cell types undergo rolling and arrest in vivo in order to be separated from a highly
heterogeneous background population [122]. For example, leukocytes are selectively recruited
from the circulation to "home in" on sites of inflammation [123], while mesenchymal stem cells
participate in organogenesis, wound-healing and natural cell turnover [124]. Similar strategies
may be utilized by circulating tumor cells prior to extravasation and metastasic colonization
[125, 126]. Many of these behaviors are associated with a porous vasculature, such as capillaries
in the bone marrow and discontinuous fenestrated sinusoid cells in the liver [127]. This vascular
permeability can be enhanced during acute and chronic inflammation as well as cancer [128].
Although cell rolling and adhesion is frequently observed along sinusoids in vivo [129], previous
in vitro assays have only used solid surfaces to elucidate the biochemical interactions between
cellular receptors and surface ligands.
By using porous surfaces with slightly larger pores, it may be possible to delve deeper into the
multistep trafficking cascade under biomimetic conditions. In particular, this geometry is highly
reminiscent of the transwell/Boyden chamber assay for chemotaxis studies [130]. After capturing
cells, the flow conditions in the microfluidic device could be reconfigured to minimize transverse
permeation while achieving identical continuous flows in the top and bottom chambers. By
loading the bottom chamber with a chemo-attractant solution, a stable gradient would be formed
through the membrane, promoting cell migration through the pores. A further step could be to
culture a layer of endothelial cells on the porous surface instead of simply patterning ligands
[131-133]. By combining biomimetic features with precisely controlled microfluidic flows, it
may be possible to recapitulate complex biological behaviors in vitro, replicating the dynamics
of the leaky vasculature within tumor microenvironments.
Fluid-permeable surfaces represent a powerful and versatile approach for specific analyte
capture, overcoming fundamental limitations associated with interfacial effects near solid
surfaces [134, 135]. This work has elucidated the physical mechanisms governing both transport
and cell-surface interactions in these conditions, establishing engineering design rules for future
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devices. An exciting prospect is to further increase the performance and utilization of this device
by designing and fabricating a tunable microfabricated porous structure that would allow better
control over the local and global shear and permeation flux. For example, fabrication of
patterned sub-wavelength porous structures in mechanically robust SiNx films using extremely
large electron beam currents has previously been shown. By defining decreasing porosity on the
surface, through different sized pores or variable frequencies of pores, it is conceivable to
maintain ideal shear along the entire channel length required to capture as opposed to a
decreasing shear in non-controllable commercial surfaces. This would lead to a more judicious
use of the surface with capture occuring along the entire length. Consequently, the channel
length and the channel dimesions can be reduced, which would reduce the area of post sample
processing investigation. This capability for efficiently processing hundreds of mL of blood may
enable transformative possibilities for point-of-care diagnostics and personalized medicine, such
as the capture of extremely rare antigen-specific T-cells or fetal cells. Further, numerous
methods available for functionalizing Si with antibody covered biodegradable polymers , opens
up possibilities of an integrated capture and release chip from blood [136, 137]. In many
applications, it is desirable to release desired bioparticles from the capture surface after isolation,
either for downstream culturing or for further counting and sorting.
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